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ABSTRACT
The goal of this dissertation is to establish the environmental and public health
importance of alternative forms of antimicrobial therapy, specifically those that utilize
nanotechnology to combat quorum sensing-controlled bacterial infections. Quorum
sensing (i.e. chemical communication) is an inherent characteristic that is essential to
bacterial pathogenesis and biofilm formation (where most infections occur). A thorough
review of the literature has been conducted to establish an understanding of the state of
nanotechnology research as it relates to combatting bacterial infections. This synthesis,
provided in Chapter 1, demonstrates how the chemical and structural designs of
nanoparticles can be manipulated to specifically target bacterial infections.
Next, an investigation into the development and novel use of nanoparticles
engineered to shut down bacterial quorum sensing is given in Chapter 2. Inhibiting the
quorum sensing process is significant because it does not kill the bacteria, and therefore
does not exacerbate antibiotic resistance. Briefly, the model system demonstrates that cyclodextrin functionalized nanoparticles are able to persist in the bacterial cell
environment and quench extracellular bacterial communication molecules, and
effectively silence bacterial communication. The system neutralizes communication
through chelation of common signaling molecules called acyl-homoserine lactones. The
new technology described here provides a seminal step in developing anti-virulence
therapies that will not contribute to antibiotic resistance, and do not rely on traditional
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antimicrobials. Also, this technology utilizes non-toxic nanoparticles that can be
functionalized with biologically-active compounds and tailored to meet specific needs.
This study provides a scaffold and critical stepping stone that will promote more-tailored
future developments in nanoparticle-based antimicrobial therapy.
Chapter 3 provides insight into the environmental importance of bacterial
communication, and the steps taken by bacteria to protect the valuable signal molecules.
Briefly, environmental biofilms consist of extracellular polymeric substances with a high
concentration of nonreducing sugars, such as trehalose. Previous studies have shown that
trehalose is commonly utilized by soil bacteria during periods of drought to maintain
membrane stability and preserve the structure of proteins. The study presented in
Chapter 3 demonstrates that trehalose plays a role in protecting quorum sensing signals
during desiccation through the formation of an extracellular glass. Additionally, the study
provides a survey of the complexity of microbial ecosystems and the role that biofilm
components play in the natural environment. Together, the three chapters of this
dissertation demonstrate the importance of quorum sensing to bacteria and as a target for
nanoparticle-based antimicrobial therapy.
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CHAPTER 1
ENGINEERED NANOPARTICLES TO ATTACK BACTERIA

The seminal realization of the nanotechnology, and its potential to be manipulated at
molecular and atomic scales developed over a half century ago.1 However, largely due to
a lack of technical capability, a time of obtuse contemplation followed. During this initial
lull in nano-based research, the 1950s and 60s saw a surge of attention in the
development of antibiotics – the wonder bullet cited to stop all bacterial disease.
However, this phenomenon was quickly tempered by a rapid emergence of antibiotic
resistance (AR) among pathogens, often in the form of multi-drug resistance (MDR). AR
continues to grow today, and at present, the future utility of traditional antibiotics remains
questionable.
The surge in nanoresearch, coupled with dramatic increases in technical
capabilities, has allowed the disparate fields of nanochemistry and antibiotics to come
together. Traditionally, nanoparticles and nanomaterials have been developed as carriers
to deliver anticancer and other forms of drugs to eukaryote cells. Given this foundation,
the delivery of antibiotics using engineered nanoparticles has become an emerging and
realistic area of research. Overcoming the problem of antibiotic resistance, however,
requires a more in-depth understanding of interactions between the biology of
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microorganisms and the physical chemistry of nanoparticles. This understanding is
necessary in order to ultimately target bacteria, and overcome their immense arsenal of
defenses. This review centers on fundamental, RAFT-based and timed-release surface
chemistry, which is currently being developed for nanoparticle delivery of antibiotics to
bacteria. We also integrate approaches being developed to enhance the detection and
quantification of bacteria within biological systems. Concurrent with this chemistry is a
necessary overview of certain bacterial processes, as these directly and indirectly interact
with the chemistry of nanoparticles.

1.1 NANOPARTICLES AS DRUG CARRIERS: A BRIEF HISTORICAL
PERSPECTIVE
Credited for conceiving the idea of a “magic bullet” to selectively target toxic
organisms in the body, Paul Ehrlich inspired many pioneers of the nanoparticle field. In
the 1950s and 60s, Peter Speiser’s group worked on the development of polyacrylic
beads,2,3 then microcapsules,4 and eventually the first nanocapsules.5 Their ultimate goal
was to achieve sustained drug release from nanocapsules in the blood after intravenous
injection.
Since that time, nanoparticles have been used for pharmaceutical and medical
applications, mainly for cancer treatment6 and enhancing the efficacy and targeting of
cancer drugs.7,8 This has allowed for the use of lower concentrations of highly-toxic
drugs in an effort to reduce side effects.9 More recently, and in conjunction with the
important discovery that polyethylene glycol chains on nanoparticles prolong blood
circulation and reduce liver uptake,10 studies have been conducted on the ability of
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nanoparticles to cross the blood brain barrier, and target deep brain tumors or
infections.11-14 The innovative research of the past 50 years has reinforced the roles of
nanoparticles as drug delivery vehicles and has inspired the current diversity in
nanoparticle research. Today, investigators focus their nanoparticle research on
recognition, sensing, imaging, and delivery in biological systems with a broad range of
core materials.

1.2 THE ANTIBIOTIC DILEMMA: THE MODE OF DELIVERY COUNTS
Antibiotics are molecules produced by microorganisms to inhibit other
microorganisms. Several major classes of antibiotics, based on their chemical structure
and mechanisms of actions, are currently known. Since bacteria produce antibiotics,
inherently they also possess mechanisms to resist their inhibitory actions, which can be
passed on to nearby cells. Bacteria have also demonstrated resistance towards the
naturally antimicrobial compounds used to construct NPs, such as silver and copper. This
section addresses the molecular structure of antibiotics, and provides a basis for
understanding their key activity sites on molecules, and how these relate to their
inhibitory action(s). It sets a stage for why and how NPs can be used to enhance delivery
and activities of antibiotics.

Chemistry of antibiotics: structure and design
Selman Waksman coined the term ‘antibiotic’ to describe any small molecule
made by a microbe intended to antagonize the growth of another microbe.15 Waksman,
along with Fleming, Chain, Florey, and many others, was a pioneer of the ‘golden age’ of
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antibiotics. Although we have been aware of the healing nature of moldy foods for
thousands of years, it was not until the 19th and 20th centuries that scientists began to
understand that the provenance of antibiotics was related to the antagonism between two
microorganisms. In 1928, British scientist Alexander Fleming witnessed the fungus
Penicillium notatum produce a compound, that he named penicillin, which prevented the
growth of the bacterium Staphylococcus aureus. By 1939, Florey and Chain manipulated
P. notatum to produce large quantities of a stable form of penicillin.16 The cooperation of
scientists from Great Britain and the United States resulted in clinical trials and the mass
production of penicillin during the final, crucial years of World War II. Also during this
period, Waksman and colleagues isolated several antibiotics from filamentous, soildwelling bacteria of the genus Actinomycetes.
Since the groundbreaking work of the 1940s, nearly 25,000 natural, synthetic, and
semisynthetic antimicrobials have been discovered. 20,000 of these are naturally
occurring drugs produced by soil-dwelling fungi and bacteria.17 Although there is an
excess of available bioactive and toxic compounds, less than 1% are clinically useful.
There are two major classes of antibiotics: bactericidal and bacteriostatic. Bactericidal
antibiotics, like the -lactam compounds penicillin and cephalosporin, kill bacteria.
Bacteriostatic antibiotics, like tetracycline and its many derivatives, inhibit the
proliferation of bacteria. Compounds that act on both Gram-positive and Gram-negative
bacteria are classified as broad-spectrum antibiotics. Compounds that act on only a
specific group of bacteria are narrow-spectrum antibiotics. The most studied and relied
upon antibiotics have been repeatedly proven to be nontoxic to humans and highly-toxic
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to pathogens. For the purpose of this review, we will briefly discuss the pharmacokinetic
and pharmacodynamic properties of the major classes of antibiotics.

Major classes of antibiotics and mechanisms of action
Pharmacokinetics describes the effects of the body on the actions of a drug. The
pharmacokinetics of an antibiotic dictates its absorption, distribution, metabolism, and
elimination by the body. Non-ionized molecules are more lipid soluble than ionized
molecules and can readily diffuse across the cell membrane. Since ionized molecules are
less able to penetrate the lipid membrane; their entry depends on the leakiness of the cell
membrane, as related to electrical resistance. The transmembrane distribution of a weak
electrolyte is influenced by its pKa and the pH gradient across the membrane, where pKa
is the pH at which half of the compound is in its ionized form. Antibiotics rely on passive
transport (paracellular transport or diffusion) or active transport (facilitated diffusion or
drug transporters) to cross cellular barriers. Due to the presence of a carboxyl group
(essentially a proton donor), -lactams are considered weak acids and do not readily cross
the cell membrane (of mammalian or bacterial cells).18
To understand the pharmacokinetic transport of an antibiotic to a bacterial cell, it
is important to briefly consider the fundamental structural differences between Gramnegative and Gram-positive bacteria (Figure 1.1).
Pharmacodynamics refers to the study of the biochemical and physiological
effects of drugs and their mechanism of action. In the case of antibiotics, the barriers
inflicted by human anatomy, the chemical properties of the antibiotic, and the presence of
multidrug transporters among the many types of cells along this pathway influence the
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efficacy of antimicrobial therapy. The penetration of physical barriers by antibiotics is
directly related to the octanol-water partition coefficient (Kow) of the antibiotic.
Generally, hydrophobic drugs (with high Kows) become concentrated in the lipid
membrane of cells, while hydrophilic drugs typically concentrate in aqueous areas such
as the blood or cytosol. Additionally, the larger and more negatively charged an antibiotic
is, the more difficult it is for that drug to penetrate cell membranes and physical
barriers.20
The extracellular concentration of an antibiotic directly affects the intracellular
concentration in a concentration- and time-dependent fashion,21-24 depending on the drug
and microorganism. An antibiotic intended to target an intracellular infection must cross
the cell membrane and retain activity in the cytosol.25 The equilibrium of free and bound
(to protein, stabilizing agent, serum, etc) antibiotics directly alters active transport, pH
partitioning, and accumulation in the host, and therefore influences its ability to cross the
cell membrane and target an intracellular infection.26 Additionally, the intracellular
activity of antibiotics is largely influenced by the pH of the vacuoles and lysosomes in
which it becomes localized, and the level of bacterial (i.e. growth rate, presence of
persister cells, and small colony variants27-29) and cellular activity.25 Alternatively, the
antibiotic oritavancin (i.e. a semi-synthetic glycopeptide) is unaffected by pH, but shows
decreased intracellular activity, likely due to binding with intra-lysosomal constituents.23

-lactams
To date, -lactam compounds are the most important broad-spectrum antibiotics
and the most commonly prescribed. The most well-known examples of the fungal-

6

derived drugs include penicillin and cephalosporin. Simply put, -lactams bind
irreversibly to enzymes intended to catalyze the transpeptidation of the peptidoglycan
layer of the bacterial cell wall. -lactams prevent proper reconstruction of a cell wall,
eventually weakening and lysing the bacterial cell.30-31
More specifically, -lactams are a large class of drugs that primarily target the
penicillin-binding proteins (PBPs) required for bacterial cell wall synthesis. This class is
characterized by a highly reactive, four-membered carbonyl lactam ring containing
azetidinone32 and includes penicillins, narrow- and extended-spectrum cephalosporins,
monobactams and carbapenems.33 -lactams target peptidoglycan biosynthesis by
blocking the insertion of glycan units into the cell wall to inhibit cell wall development
and by blocking transpeptidation linking and maturation.34 Peptidoglycan, found in both
Gram-negative and Gram-positive bacteria, is an integral part of the cell wall that is
required by bacteria to maintain the structural integrity of the cell and to survive changes
in environmental osmotic pressure.35 -lactams form a covalent complex with enzymes
(the PBPs) that generate the mature peptidoglycan molecule. The -lactam antibiotic,
containing a cyclic amide ring, mimics the D-alanyl-D-alanine region of the PBP, forms a
covalent acyl-enzyme complex with the activated serine of the PBP that inhibits the
peptide bond formation reaction catalyzed by PBPs, and is mistakenly incorporated into
the cell wall.30-31, 36 This complex inhibits transpeptidation activity and weakens the
integrity of the cell wall, eventually resulting in cell lysis.36 Specifically, the PBP
inhibition occurs by penicilloylation of the active site, which blocks the hydrolysis of the
bond created with the now open-ringed drug and disables the enzyme.32, 37-38 A review by
Kohanski and colleauges additionally explores alternative targets of -lactam activity
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such as cell division, autolysin activity, the SOS response, the TCA cycle, Fe-S cluster
synthesis, ROS formation, and envelope and redox-responsive two-component systems.32
Although -lactam antibiotics are highly effective against susceptible bacteria,
they are most useful against extracellular infections within the body. Intracellular
pathogens, such as Listeria monocytogenes and Salmonella species, are protected from
the immune system by phagocytes and are less accessible to these antibiotics. Reports
show poor accumulation of -lactams in phagocytic and nonphagocytic cells, possibly
due to the acidic conditions of the cytosol and the presence of multidrug efflux pumps in
both human and bacterial cells.39,40 The free carboxylic group on -lactams is essential to
activity, and makes them a weak acid. Due to the acidic nature of the cytosol of
phagocytic and nonphagocyctic cells, -lactams cross the membrane very slowly, if at all.
The efficacy of -lactams is dependent upon time of exposure above MIC, so slow
penetration renders them less effective at targeting intracellular pathogens.41
Resistance to -lactams arises through mutations in PBPs,42 acquisition of new
PBPs with lower affinity for the drug,43 production of -lactamases that inactivate the
drug by hydrolyzing the -lactam ring,33, 42, 44-45 changes in cell wall porins that limit
entry of the drug to the target site, and active efflux of the drug out of the cell by energydependent pumps.34 Bradford46 provides an in-depth review of the characterization and
epidemiology of plasmid and transposon mediated -lactamases. Information on lactamase inhibitors, compounds used concurrently with -lactam antibiotics to fight
resistant bacteria, can be found in papers by Drawz & Bonomo and Therrien &
Levesque.33, 47 A detailed overview of bacterial resistance to -lactam antibiotics was
published by Fisher and colleagues.48
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Tetracyclines
Tetracyclines are another group of medically-relevant antibiotics. They are
bacteriostatic against a broad spectrum of Gram-positive and Gram-negative bacteria, and
several protozoans. Tetracyclines act through interrupting protein synthesis by inhibiting
the aminoacyl-tRNA from binding to the 30S ribosomal subunit of bacterial RNA. The
antibacterial activity of tetracyclines is derived from the linear fused tetracyclic nucleus
of six-membered carbocyclic rings, and their strong chelating ability.49
The basic structure of the tetracycline group of antibiotics consists of a linear
fused tetracyclic nucleus with a variety of constituents. These structural features confer
antibacterial activity to the tetracyclines.49-52 Several structure-activity studies have
demonstrated that the rings of tetracycline must contain six members and be purely
carbocyclic to retain antibiotic activity.49 The review by Chopra49 has detailed the mode
of action of tetracycline. Briefly, in Gram-negative bacteria, which have both an outerand inner-membrane, tetracycline diffuses across the outer membrane through porin
channels as a positively-charged metal complex. The metal ion-antibiotic complex
accumulates in the periplasm where it dissociates, and the uncharged tetracycline diffuses
through the lipid bilayer of the cytoplasmic (i.e. inner) membrane. At this point,
tetracyclines bind to the small ribosomal subunit and prevent the association of
aminoacyl-tRNA with the ribosome and inhibit protein synthesis. Tetracyclines are
strong chelators and are likely to become chelated within the cytoplasm. Therefore, the
complex that binds to the 16S rRNA likely contains magnesium. Association of
tetracycline and the ribosome is reversible and may explain the bacteriostatic properties
of the drug.49, 53-54
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Aminoglycosides
Aminoglycosides (AGAs) were one of the first discovered and clinically used
antibiotics. Hence, they are also one of the most resisted by human pathogens. The
structure of AGAs varies. In general, AGAs consist of an inositol derivative linked to an
amino-sugar and a variety of free hydroxyl and amino groups, potentially containing
further substituents. These free groups interact with the 30S subunit of ribosomal RNA
and interfere with protein translation. More specifically, AGA binds three adenines
present in the A-site of the 30S ribosomal subunit. Binding stabilizes the 30S subunit,
which subsequently allows the noncognate tRNA to bind and initiate a misreading of the
mRNA, followed by the synthesis of faulty proteins.55 It is unknown how the loss of
translational fidelity leads to cell death,56-57 but it has been suggested that the use of
faulty proteins in the inner membrane destabilizes the cell.58-60 Resistance against AGAs
by bacteria is inferred by aminoglycosidic-modifying enzymes (acyltransferases,
phosphotransferases, nucleotidyltransferases, methyltransferases), target modification by
mutation, change of uptake and efflux, and membrane proteases. A recent review by
Becker and Cooper55 goes into specific detail.

Macrolides
The macrolides are a class of natural and semisynthetic bacteriostatic antibiotics
that are often used to treat respiratory, skin, and soft tissue infections. Macrolides contain
a large lactone ring (12-16 atoms) attached to sugars with glycosidic bonds and
substituted by hydroxyl or alkyl groups. Macrolides are subdivided into four classes
based on the number of atoms in the lactone ring (12, 14, 15, and 16-membered rings).
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Although the precise mechanism is unknown, macrolides bind to the 23s rRNA portion of
the 50S ribosomal subunit to block protein synthesis.61 Kannan & Mankin62 provide a
review of the binding and action of macrolide antibiotics in various microorganisms.
They explain that macrolides bind in the nascent polypeptide exit tunnel of the large
ribosomal subunit close to the peptidyl transferase center (PTC). In this position,
macrolides inhibit the movement of proteins out of the ribosome and prevent translation
elongation.61, 63-64 The macrolide establishes hydrophobic interactions with the rRNA
residues belonging to domains II and V of the 23S rRNA. Crystallographic evidence has
demonstrated that the macrolactone is positioned flat against the wall of the ribosome
with the side chains protruding up towards the PTC active site and down the tunnel
towards the exit. Although highly conserved, the slight variation in rRNA sequences
among bacteria contributes to the spectrum of activity of macrolide antibiotics and
indicates that the binding sites and modes of action may be species-specific.65 A brief
review by Gamerdinger & Deuerling66 summarizes that inhibition of protein translation
in the nascent peptide exit tunnel may be regulated by small metabolites and may play an
important global role in cellular physiology. The inhibitory action of macrolides on the
bacterial ribosomal tunnel is selective. Kannan et al. found that macrolides allow
selective synthesis of full-sized and truncated proteins in bacteria,67 an action that
influences the cellular proteome and may enhance toxicity.

Sulfonamides
Sulfonamides are a structurally-related group of broad spectrum, bacteriostatic,
synthetic antibiotics used for systemic application. Originally known as sulfa drugs,
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compounds of this class of drugs contain a 4-aminobenzene sulfonamide backbone that
inhibits the growth and reproduction of bacteria by competing with p-aminobenzoic acid
during folic acid synthesis.68 Sulfonamides are unique polar molecules with amphoteric
properties. At pH 2-3, the amino nitrogen is protonated, while at pH 4.5-11, the amide
nitrogen is deprotonated.69 Application of these drugs began in the early 1940s, but was
quickly phased out due to frequent bacterial resistance. Because of widespread resistance,
sulfonamides are rarely used alone. Currently, combination drugs containing both
sulfonamides and diaminopyrimidines are used to treat both Gram-positive and Gramnegative infections.
A brief review of the mechanisms of action and resistance of sulfonamides are
presented by Skold70. Sulfonamides interrupt the essential folic acid synthesis pathway in
bacteria by mimicking p-aminobenzoic acid (pABA) and inhibiting dihydropteroate
synthase. Often used in combination with sulfonamides, diaminopyrimidine next targets
dihydrofolate synthase (DHPS), an essential enzyme of the folic acid synthesis pathway.
DHPS catalyzes the condensation of p-aminobenzoic acid and 7,8-dihydro-6hydroxymethlpterin-pyrophosphate (DHPPP) to form dihydropteroic acid (the second to
last step in the folic acid synthesis pathway). At this point, the sulfonamide is bound to
DHPS. Crystallography shows that the sulfonamide is sandwiched between the main
chain of Arg 200 and the side chain of Lys 221 on one side and the side chain of Arg 63
on the other of DHPS. The sulfonamide NH2 donates a hydrogen bond to the carbonyl of
Ser 219 and one sulfonamide oxygen accepts a hydrogen bond from the guanidinium of
Arg 63 of DHPS.71 The competitive inhibition of DHPS by sulfonamides halts the folic
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acid synthesis pathway and inhibits the growth of bacteria by eventually starving the cell
of folic acid.
Bacteria exhibit resistance to sulfonamides through point mutations that affect
binding of the inhibitor or through the acquisition of drug-insensitive enzymes that
bypass the antibiotic-sensitive step of folic acid synthesis.34

Lipopeptides
Lipopeptides are a class of drugs including both natural and semi-synthetic
antibiotics that target bacterial cell wall synthesis in Gram-negative and Gram-positive
species. Lipopeptides are used in a range of applications as antimicrobial, antitumor,
immunosuppressant, and surfactant agents. The lipopeptides are a structurally diverse
class of antibiotics that contain a short linear peptide or an oligopeptide of either net
negative or positive charge. The peptide portion of the lipopeptide varies in length and
amino acid composition, and is covalently attached to a fatty acid at the N-terminus of the
lipid moiety. In general, lipopeptides target the bacterial cell membrane and are highly
active against multi-drug resistant bacteria. Specifically, lipopeptides form pores in the
bacterial cell membrane, which leads to an imbalance in transmembrane ion flux of K+,
H+, and Ca2+, and cell death.72-73
Lipopeptides, such as the anionic amphomycin and daptomycin, bind directly to
the bacterial cell membrane where they interact with the lipid bilayer via electrostatic and
hydrophobic interactions to cause rapid depolarization of the bacterial membrane
potential.74-77 Upon interaction with the membrane, the peptide adopts a three
dimensional structure and becomes amphiphilic, with the positively-charged side
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interacting directly with the lipid head groups. The formation of a secondary structure is
essential for the interaction of amphiphilic molecules with the bacterial cell membrane.78
The anionic compound daptomycin is active against Gram-positive bacteria, and
requires calcium to lock into an active conformation. The addition of calcium ions leads
to oligomerization of daptomycin and induces the formation of micelle-like structures.7879

The lipid tails point inward and the calcium ions help hold the charged side chains of

daptomycin from different monomers together. Calcium is weakly bound (i.e., the system
requires 1000 times more calcium than daptomycin) so the micelle can readily dissociate
at the cell membrane surface.80 The initial binding event between the daptomycin
aggregate and the bacterial membrane may be with the membrane lipid phosphatidyl
glycerol.81 Daptomycin binds strongly to phosphatidyl glycerol head groups in the
bacterial cell membrane.82 The large aggregates alter the membrane shape, leading to
membrane leakage and eventual cell death. The daptomycin aggregates may also interfere
with membrane-associated processes such as cell wall synthesis, cell division, and
energetics.83 A detailed review of daptomycin in clinical microbiology is given by
Humphries and colleagues.83

Glycopeptides and glycolipopeptides
The glycopeptides and glycolipopeptides are a class of natural and semi-synthetic
drugs derived from actinobacteria that target peptidoglycan synthesis in Gram-positive
bacterial cell walls. The glycopeptides and glycolipopeptides act by binding to
peptidoglycan units at the D-alanyl-D-alanine dipeptide terminus to block
transglycosylase and PBP activity.84-85 These compounds act as steric inhibitors of

14

peptidoglycan maturation and reduce the mechanical strength of the cell. Some semisynthetic glycopeptides have been shown to interact directly with transglycosylase.86
Kahne and colleagues have extensively reviewed the structure and function of
glycopeptides and glycolipopeptides.84

1.3 DIRECT AND INDIRECT ANTIMICROBIAL PROPERTIES OF
INORGANIC NANOPARTICLES
Unique physical-chemical properties of inorganic nanoparticles have been utilized
for hundreds of years. More recently, certain types of inorganic NPs have been found to
exhibit strong antimicrobial properties. However, their applications as antimicrobial
agents are limited by their apparent toxicity to other biological systems (e.g. human
cells). This section examines major types of inorganic NPs, and discusses the chemistry
of their toxic- and/or non-toxic properties and antimicrobial mechanisms of action. This
section also provides an overview of the methods used to determine efficacy of inorganic
nanoparticles (luminescent biosensors, generation of ROS, DNA damage, cell membrane
integrity, electron microscopy, live/dead assays, Raman scattering, SDS-PAGE analysis
of proteins, gene expression, etc.) in a bacterial system. Given the ability of bacteria to
protect themselves from natural stresses and reach a ‘viable but nonculturable’ (VBNC)
state, techniques alternative to traditional culturing are required to judge the antimicrobial
properties of inorganic nanoparticles.
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Silver nanoparticles
The antimicrobial nature of silver, and silver compounds, has been utilized for
hundreds of years. The surge of antibiotics in the 1940s reduced the medicinal reliance on
silver, but in recent years there has been a comeback in its uses for wound- and burndressings in a number of forms, including silver nanoparticles. Silver nanoparticles, in
addition to silver ions, metallic silver, silver nitrate, silver sulfadiazine, and silver zeolite,
typically encounter minimal bacterial resistance and possess strong bactericidal
properties.87-90
The antimicrobial effect of silver nanoparticles has been seen in Gram-positive
bacteria, Gram-negative bacteria, and yeast.91-95 Silver nanoparticles are effective at
preventing growth of bacteria on surfaces of agar plates, but are comparatively lesseffective in liquid medium, due to aggregation of colloidal silver in the presence of high
salts and other media components.94, 96-97 These studies suggest that the antimicrobial
ability of silver nanoparticles is dependent upon surface oxidation (of the nanoparticle)
and particle dispersion. The size and shape of silver nanoparticles also play a major role
in their ability to interact with the bacterial surface and release silver ions (Ag+) into
solution. Given their enhanced surface area, smaller, spherical nanoparticles (1-10 nm)
are more effective at attaching to the surface of a cell membrane and disturbing
permeability and respiration than larger nanoparticles.96, 98-99 Thus, reducing the size and
increasing the surface area of nanoparticles provides a greater number of reactive groups,
Ag+ in this case, and is believed to enhance nanoparticle toxicity.100-102 Small
nanoparticles penetrate the bacterial cell membrane and interact with the thiol groups of
protein, preventing expression of ribosomal subunit proteins, deactivating the enzymes
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and cellular components essential to ATP production,99 and by preventing DNA from
replicating.88, 98
The mechanism of action of silver nanoparticles is not entirely understood, but
current research has demonstrated that silver ions affect essential cellular components
(cell membrane integrity, respiration, and ATP production). To date, there have been very
few observations reported for microbial resistance against silver. Originally discovered in
Salmonella typhimurium,103 and then later in Pseudomonas aeruginosa, Candida
albicans, and the environmental isolate Acinetobacter baumannii, silver resistance has
been the result of both intrinsic and acquired genes.104 The distinction between silver
sensitivity and silver resistance is difficult to determine, however, because silver resistant
phenotypes are not consistent. Silver resistance may be incurred by plasmids, specialized
rapid-efflux pumps, or genetic mutations that are repaired after silver pressure has
diminished. 89, 104-105
Medical devices and wound dressings impregnated with silver nanoparticles have
made a large impact on reducing infection in hospital settings;106 however, the toxicity of
these compounds on humans is not fully understood. Cytotoxicity of silver nanoparticles
on mammalian cells has been observed in vitro, demonstrating that silver nanoparticles
may enhance the generation of reactive oxygen species100, 107 and damage DNA.108-109
The potential for extensive DNA and cell damage is a precursor for carcinogenesis.110
Although the primary condition currently associated with silver is the cosmetic ailment
known as argyria (irreversible bluish-gray discoloration of the skin), further research is
required before relying on silver nanoparticles as an antimicrobial agent. A thorough
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review of the effects of nanoparticles on the cell life cycle is provided by Mahmoudi et
al.111

Titanium dioxide nanoparticles
Titanium dioxide (TiO2) is a naturally-occurring compound that has been used
extensively in cosmetics, sunscreen, and food additives because of its highly refractive
qualities. Additionally, TiO2 nanoparticles have been utilized for their antimicrobial
properties. When photoactivated by UV or visible light, TiO2 catalyzes the cleavage of
water into hydrogen and oxygen, and produces reactive oxygen species (ROS) in
solution.112 Currently, TiO2 nanoparticles, which can be activated by weak UV light, are
used in interior furnishings such as tiles and wallpaper in hospital rooms, air conditioning
and purification units, wastewater/sewage purification systems, and pollution abatement
strategies to reduce bacterial loadings.113
Several studies have been performed to determine the antimicrobial efficiency of
TiO2 nanoparticles. After photoactivation, TiO2 nanoparticles were highly toxic to E. coli
and P. aeruginosa.114-117 The degree of toxicity was directly related to the cell wall of the
microorganism, as E.coli (Gram-negative) was more susceptible than S. aureus and E.
faecalis (Gram-positive), which were more susceptible than the fungi C. albicans and A.
niger.118
The mechanism of action responsible for killing microorganisms exposed to
photoactivated TiO2 is only partially understood. It has been theorized that the ROS
generated through photoactivation are responsible for the antimicrobial efficacy of
TiO2.119 ROS are able to damage the cell membrane and disrupt essential membrane-
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bound proteins,120 in addition to creating single stranded or double stranded breaks in
DNA, rendering it unable to be replicated.121-122 The antimicrobial activity of ROS varies
between environments and experiments; therefore the exact mechanism of action is not
fully understood nor agreed upon.123 Macrophages of mammalian immune systems rely
heavily upon ROS to eliminate pathogens from the body. Therefore, microorganisms are
exposed to ROS often, and have inherent defense mechanisms in place for protection. For
example, Salmonella typhimurium sequesters iron ions to protect their DNA from ROS,
in addition to the expression of a Type III secretion system that prevents the host cell
from reducing hydrogen peroxide (H2O2) to the more-deadly superoxide anion O2-.124, 125
Additionally, Salmonella enterica possesses several antioxidant enzymes that detoxify
ROS.126,127 The inherent nature of photocatalysis and the creation of ROS limit the
antimicrobial efficacy of titanium dioxide nanoparticles to aerobically grown organisms
in water, air, or on surfaces.

Gold nanoparticles
Colloidal gold has been used by scientists and medical practitioners for well over
a thousand years. In the present day, due to its exceptional ligand binding ability,
spectroscopic detection, high contrast in electron microscopy, and general stability, gold
nanoparticles are widely used in biological and chemical systems. Extensive reviews on
the syntheses and applications of gold nanoparticles have been published.128-130
Gold nanoparticles are readily taken up by host immune cells, thus enhancing
their ability to deliver drugs to intracellular microbial pathogens.131 The exceptional
binding of gold nanoparticles allows higher concentrations of complexed drugs to be
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delivered to an affected area without releasing high levels of free, toxic drugs into the
broader system. Gold nanoparticles lack the inherent antimicrobial effects noted for silver
and titanium dioxide nanoparticles, therefore the simple presence of gold nanoparticles in
solution with antibiotics is not enough to enhance the efficacy of antibiotics.132-133
However, antibiotics, when conjugated to gold nanoparticles confer an increased and
more targeted local concentration (of antibiotics) and help destroy microorganisms more
efficiently than antibiotics alone, while reducing levels of toxic drugs in the system. For
example, conjugation of ampicillin, streptomycin, and kanamycin to gold nanoparticles
decreased their minimum inhibitory concentrations (MIC) to the bacteria Escherichia
coli, Staphylococcus aureus, and Micrococcus luteus. In addition to enhancing the
efficacy of these drugs, conjugating the antibiotics to gold nanoparticles also made these
drugs more stable and heat tolerant.134
Conjugating antibodies to gold nanoparticles can allow for the targeting of
specific microorganisms. Pissuwan et al. demonstrated that when antibodies were
conjugated to gold nanoparticles, they selectively targeted and destroyed the parasitic
protozoan Toxoplasma gondii after plasmonic heating.135 The in vitro experiment with
antibody-conjugated gold nanoparticles killed approximately 80% of the parasite,
whereas the antibody or gold nanoparticles alone did not kill a significant number of
protozoa. Norman and colleagues used a similar approach to target the a multi-drug
resistant strain of Pseudomonas aeruginosa.136 In their experiment, near-infrared
irradiation was used to photothermally heat gold nanoparticles attached to P. aeruginosa,
resulting in membrane disruption and 78% cell death. Additionally, vancomycin
conjugated gold nanoparticles demonstrated activity against vancomycin-resistant
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Enterococci, vancomycin-sensitive strains of Enterococci and other Gram-negative
bacteria.137

Carbon nanotubes
Carbon nanotubes are single-wall (SWNT) or multiwall (MWNT) cylinders of
graphene, valued for their unique size- and structure-dependent properties.138 Due to their
strength and thermal and electrical conductivity, carbon nanotubes have a wide range of
commercial applications. The synthesis and use of commercial carbon nanotubes has
been thoroughly reviewed.139-144 Recently, the biological toxicity of carbon nanotubes has
become a pressing issue as humans and the environment come into more frequent contact
with the nanomaterials.145-148 Studies have defined the major mechanisms of toxicity to
eukaryote cells to be oxidative stress, agglomeration, physical interactions, nutrient
sequestering, shading effects, and metal catalyst residues.149-156 The potential for stress to
humans and the environment indicates that other living organisms, such as bacteria and
fungi may also be susceptible to carbon nanotubes. Currently, the exact mechanism of
toxicity of SWNT towards bacteria is unknown; however, several studies have confirmed
that membrane damage is a common result of SWNT treatment. The role of oxidative
stress is still debated.157
One of the antibacterial first studies, conducted in 2007, showed that direct
contact of carbon nanotubes with E. coli outer membranes caused irrecoverable damage
and cellular lysis.158 Since then, multiple reports have confirmed that SWNT induce
membrane damage and oxidative stress. A major challenge in using carbon nanotubes as
antimicrobial agents is the widespread and broad toxicity of the nanomaterials.159-161
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Modified SWNT have also demonstrated exceptional antibacterial activity.
Vecitis and colleagues showed a significant loss in E. coli viability due to both membrane
damage and oxidative stress with an increasing fraction of metallic SWNT.162 They
suggest that the electronic structure of SWNT contributed to oxidative stress, while the
physical structure damaged cell membranes. The difficulty in utilizing SWNT lies in their
ability to nonspecifically damage many cells. However, functionalized SWNT have
demonstrated lower toxicity to human cells than pure SWNT,163-166 while maintaining
antibacterial activity. To this point, a recent study has shown that surface functionalized
SWNT have enhanced functionality against microbes (as demonstrated by loss of cell
wall integrity) with decreased cytotoxicity of human cells.167 The study showed that
aggregation and dispersity of the SWNT were the major contributors to toxicity.
Similarly, SWNT/PLGA composites have been shown to possess antimicrobial activity
against E. coli and Staphylococcus epidermidis upon contact.168 Contact-driven toxicity
may be related to the ability of the tube ends to puncture cell membranes, as short SWNT
had a high density of uncapped tube ends and were found to be more toxic than longer or
capped SWNT. The role of SWNT/PLGA composites is significant in the development of
films for biomedical implants that do not promote bacterial growth. The ability of SWNT
to inhibit biofilm growth, which is often seen on biomedical implants, has been
demonstrated in both Gram-negative169 and Gram-positive bacteria.170

Iron oxide nanoparticles
Iron oxide nanoparticles with a diameter size of 50-100 nm were first applied in
magnetic resonance imaging more than 20 years ago.171 Magnetic nanoparticles with a
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diameter of 10 nm were used in cancer therapy due to the hyperthermia effect.172 For
drug delivery applications, magnetic nanoparticles have been utilized to carry
doxorubicin, human serum albumin, and cottonseed oil to for cancer treatment.173 In
addition, surface functionalization was conducted on magnetic nanoparticles with ligands
and polymers to load drugs.174-175 Recently, magnetic SiO2 nanoparticles were used to kill
pathogenic bacteria.176 As drug delivery vehicles, magnetic nanoparticles possess the
unique advantage of guiding the nanoparticles to a desired location and keeping them
localized at the site using an external magnet.

Porous nanoparticles
The future of nanomedicine and drug delivery rests upon the ability of
nanoparticles to complex a high concentration of drugs, release those drugs in a
controlled and timely manner, control breakdown of the drug-nanoparticle matrix, have
easily manipulated surfaces, and be detectable in vivo.177 Porous nanoparticles, such as
silicon, iron (III) carboxylate, and manganese oxide, are ideal carriers for drugs having
the previously listed capabilities.177-179 Silica nanoparticles have been widely applied as
carriers for delivery of enzymes, antibiotics, and DNA.180 The biocompatibility of silica
nanoparticles makes them an especially ideal carrier for applications associated with the
human body. As an important class of silica materials, mesoporous silicas have attracted
huge interest since their initial synthesis by Mobil Corporation in 1992.181 Mesoporous
silicas have been widely utilized in the fields of catalysis and biomedicine182-183 because
of their uniquely large surface area, controllable particle size and pore size, uniform pore
structure, and easy surface functionalization. Although not inherently antimicrobial, these
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nanoparticles have the potential to be designed to carry antibiotics to multidrug resistant
infections. Currently, researchers are focusing on utilizing porous nanoparticles to deliver
anticancer drugs into tumors with incredible accuracy184-185. Given the scope of the field
of porous nanoparticles and drug delivery, further details will not be discussed here.

Methods to determine efficacy of inorganic nanoparticles on bacteria
Given the ability of bacteria to protect themselves from natural stresses and reach
a ‘viable but nonculturable’ state, techniques alternative to traditional culturing are
required to judge the antimicrobial properties of inorganic nanoparticles. Bacterial cell
culture techniques are frequently used in conjunction with other methods, such as
luminescent biosensors, detection of reactive oxygen species, cell membrane integrity
determination, and electron microscopy.
For example, the toxicity of silver nanoparticles on the growth rate of E. coli is
often determined by UV spectroscopy (OD 600 nm) of bacterial cultures.97 Many other
studies rely on traditional agar plates to count colony forming units during or after
nanoparticle exposure. As an alternative and additive to these methods, bioluminescent
bacteria such as Vibrio fischeri and genetically modified E. coli have been used in
nanoparticle ecotoxicological studies. The V. fischeri bioluminescent “Flash Assay” is
useful for screening highly turbid nanomaterials that would otherwise confound UV
spectroscopy measurements.186-189 In addition to bacterial biosensors that indicate the
overall toxicity of inorganic nanoparticles, bacterial biosensors have also been developed
to detect the presence of inorganic nanoparticles. Blinova and colleagues presented a
study using zinc and copper sensitive strains of bioluminescent E. coli. In this study, the
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bioluminescence of the genetically modified E. coli increased proportionally with the
increase in available zinc or copper.190 As an alternative to biosensors, the physical
appearance of bacteria during nanoparticle exposure has also been used to determine
toxicity.
Using electron microscopy, the membrane organization of bacterial cells can be
visualized to determine if the nanoparticle treatment induced cellular lysis or cell wall or
cell membrane damage.97, 136, 191 Less powerful microscopic techniques are also used to
determine cell viability after nanoparticle exposure. Bacterial membrane integrity can be
assayed with a fluorescent LIVE/DEAD stain (Syto9 and propidium iodide), and
visualized via confocal scanning laser microscopy.136, 183, 192 In this assay, cells with
intact membranes take up Syto9, while cells with disrupted membranes (and considered
dead) are stained with propidium iodide. Fluorescence stains can also be utilized to detect
the burst of free radicals and reactive oxygen species from bacteria during nanoparticleinduced death. The oxidation of 2’, 7’-dichlorofluorescin-diacetate (DCFH-DA) can be
used to quantitatively determine the formation of ROS by bacteria under a
microscope.193-195 These alternative techniques to growth studies are important in their
ability to determine cell viability without relying on cell culture techniques.

1.4 LINKING ANTIBIOTICS TO INORGANIC NANOPARTICLES:
CHALLENGES IN SURFACE CHEMISTRY DESIGN
The application of nanoparticles as drug delivery vehicles has attracted great
attention in past decades. Nanoparticles possess unique properties, such as monodistribution of nanoparticle size, and thermal and magnetic properties.196 In addition,
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owing to their unique physicochemical properties when compared to larger particles,
provides the potential for nanoparticles to penetrate and reach areas of bio-membrane
systems where dissolved molecules reach less-effectively. In the present section, we will
explore how nanoparticle-based drug delivery vehicles can improve the solubility,
pharmacokinetics and stability of free drugs.197

Surface functionalization
Surface functionalization of nanoparticles is of great interest because of their
potential applications in chemosensors, coatings, organic light-emitting devices (OLEDs)
and biomedical engineering.198 In the biomedical field, surface functionalization plays a
critical role in tailoring the properties of nanoparticles for enhanced binding capabilities
for therapeutic delivery,199 selective recognition within biological systems,200 and
improved cellular internalization.199

Charged moieties
Positive charges, negative charges, and zwitterionic moieties have been
functionalized onto nanoparticle surfaces. Cationic compounds have been considered
important candidates for antimicrobial agents throughout the past twenty years. Among
them, quaternary ammonium (QA)201 and phosphonium-based compounds202-203 are two
main forms of these agents. QA compounds are the most important and commonly-used
cationic agents used to kill bacteria. Dong and coworkers modified magnetic
nanoparticles with poly(quaternary ammonium) (PQA) to kill E. coli, which retained a
100% biocidal efficiency over eight-cycles of usage of the nanoparticles.204 Tiller and
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coworkers functionalized glass slides with poly(4-vinyl-N-alkylpyridinium bromide) to
kill airborne bacteria on contact.205 The antimicrobial properties of QA compounds are
likely ascribed to their interactions with bacterial cell membranes, which subsequently
results in disruption of the membranes.206-208 Carmona-Ribeiro reviewed the specific
functions of cationic materials when interacting with bacterial cell membranes and
summarized several general steps for disruption of cell membranes.209 We refer interested
readers to the literature for detailed information in this field.
QA compounds can also be used as drug delivery vehicles to load and release
antibiotics. Lee et al. have demonstrated that MSN can be functionalized with surface
positive charges to deliver an anionic anti-inﬂammatory drug, sulfasalazine, with
controllable loading, and release by changing pH value.210 The positive charge surface
was synthesized by a condensation reaction between trimethylammonium (TA)-silane
and tetraethoxysilane (TEOS) of MSN. Sulfasalazine was loaded into the nanoparticle
and remained in the framework of MSN under acidic conditions. It was then released by
electrostatic repulsion from the gradually-formed negative surface charges that developed
under neutral conditions (Figure 1.2).
Surface functionalization with negatively-charged compounds has also been
widely investigated for antimicrobial or other biomedical applications. It is reported that
positively charged nanoparticles demonstrate higher internalization in eukaryote cells,
while negatively charged nanoparticles are taken up by diffusion.211 Surface attached
anionic compounds can be employed as drug delivery vehicles to kill bacteria. Riffle and
coworkers modified Fe3O4 nanoparticles with block copolymers PEO-b-PAA.212 The
unattached segments of PAA provide thousands of anionic carboxylates which was used
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to conjugate cationic aminoglycoside antibiotics via ionic complexation for therapeutic
applications. The delivery vehicles can also be used to deliver moieties such as metal
ions. Anionic poly(3-sulfopropyl- methacrylate) brushes were prepared on Si/SiO2
surfaces and employed to complex silver ions inside the brushes.213 The surface-attached
silver-containing brushes inhibited the growth of both Gram-negative and Gram-positive
bacteria.
Zwitterionic materials (also called inner salts) with one pair or multiple pairs of
positive and negative charges in their structures have also been anchored on a variety of
surfaces. Surface attached zwitterionic materials were shown to be resistant to bacterial
adhesion and biofilm formation.214 However, most of the applications of these surface
attached zwitterionic moieties are still used in the antifouling field. These anchored
zwitterionic materials are found to highly-resist to protein adsorption. The two main
zwitterionic materials are based on sulfobetaine (SB) and carboxybetaine (CB). Thus, SB
based sulfobetaine methacrylate and CB based carboxybetaine methacrylate materials
have been widely investigated as antifouling materials.214-223
Surface functionalization using different charge moieties can be characterized by
a zeta potential test.224 This test reveals the surface electrical potential, which can be used
to analyze their stability in solution. Generally, nanoparticles have been demonstrated to
exhibit a stable dispersion in solution when the zeta potential is above ±30 mV. It is well
known that the surface charge can inhibit aggregation of nanoparticles, thus surface
modifications that introduce appropriate amounts of charges are an effective method to
store nanoparticle suspensions.
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Ligands and polymers
Relatively small molecules represent an operational class of materials that have
been widely used to modify the surfaces of nanoparticles. They provide several
advantages, such as low molecular weights, easy coordination onto nanoparticles, and
easy processing conditions. Compared to macromolecules, the relatively smaller size of
these molecules makes surface functionalizations with multiple ligands much easier. In
the last section, charged small-molecule compounds were reviewed for surface
modification. Thus, this section will only cover non-charged small-molecule ligands.
A wide range of small molecule ligands (SMLs) have been coated onto
nanoparticles for applications in biosensing, diagnosis, and drug delivery.225-230 Those
ligands can alter the nanoparticle’s stability, hydrophobic/hydrophilic properties, zeta
potential, cytotoxicity, and the interactions with cells.231-233
Small molecules provide a repulsive layer on particle surfaces, which can enhance
the stability of nanoparticles in suspension and minimize nanoparticle aggregations. Two
factors should be considered while choosing SMLs for nanoparticle stabilization: 1) the
substrate particles, and 2) the dispersion solvent. Generally, silane SMLs are used to
modify SiO2 nanoparticles, thio SMLs are suitable to coat Au-nanoparticles and
phosphate-based SMLs can be employed to functionalize iron oxide and TiO2
nanoparticles. De and coworkers have summarized the surface functionalization of a
variety of nanoparticles with corresponding SMLs.234 In all of the nanoparticle surface
functionalizations, SMLs were bound to surfaces via chemical absorption or physical
absorption (hydrophobic/ hydrophilic interactions). The dispersion solvents consisted of
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organic solvents and water. Choosing appropriate solvents with a polarity close to that of
the dispersion solvent is a necessary step while modifying particles.
Ligand exchange is a significant method to enhance the stability of nanoparticles
in certain solvents. In this process, strongly bound ligands are typically used to replace
weakly bound molecules to pursue firm surface attachment. For example, oleic acid, a
significant and commonly used ligand for stabilizing metal oxide nanoparticles, is a
weakly bound molecule and is generally exchanged with phosphate- and silane-based
ligands235-237 for firmer attachment. Schadler et al. reported using a phosphate-azide
ligand to replace oleic acid on TiO2 and ITO surfaces,238 followed by further
functionalization via “click chemistry” on the new ligand.
Generally, oleic acid or oleylamine are added to stabilize magnetic iron oxide
nanoparticles in the preparation process. However, it limits the surface functionalization
of particles and reduces the dispersion of the particles in hydrophilic media. Thus, ligand
exchange is necessary for further applications of magnetic iron oxide nanoparticles.
Bronstein and co-workers used N-(6-aminohexyl)-aminopropyltrimethoxysilane to
replace oleic acid on iron oxide nanoparticles to stabilize the particles.239 Binder and coworkers employed 1,2-diols bearing -azido or -bromo ligands to replace octylamine or
oleic acid on -Fe2O3 nanoparticles followed by post-functionalization of the new ligand
to obtain fluorescent properties.240 Sun and coworkers replaced oleylamine via ligand
exchange to convert the nanoparticles from hydrophobic to hydrophilic for develop a
stable dispersion in an aqueous environment.241 Hatton et al. replaced oleic acid with
various hydroxyl group containing ligands followed by post-functionalization for surfaceinitiated ATRP polymerizations.242
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Ligand exchange is also an important tool for surface modification of
nanocrystals. Murray and co-workers used nitrosonium tetraﬂuoroborate to replace oleic
acid or oleylamine on nanocrystals to stabilize the nanocrystals in various hydrophilic
solvents and made the ligand exchange reversible.243 Talapin et al. used metal
chalcogenide complexes to exchange ligands on nanocrystals, an exchange that resulted
in a hydrophilic property.244-245 In addition, surface functionalization of nanocrystals via
ligand exchange has been widely explored in a variety of environments to obtain new
properties.244-252
Surface coating of polymers on particles impart new properties to the surfaces.253254

The coatings can be used to further manipulate the nanoparticle’s stability in

suspensions, the hydrophobic and hydrophilic properties, cytotoxicity, biocompatibility,
and even interactions with cells. It also provides an additional platform to control the
antibiotic loading and release on nanoparticles in drug delivery systems. In this section, a
variety of common surface-modified polymers that were developed in recent years will
be reviewed based on the class of the polymer.
Polymers containing cationic moieties have been coated onto surfaces to kill
bacteria.255-257 The mechanism of the antimicrobial effect of cationic polymers has been
discussed in the previous section. Generally, this class of polymer processes alkyl
pyridinium or quaternary ammonium groups.258 Many quaternary ammonium based
cationic polymers are prepared based on 2-dimethylaminoethyl methacrylate
(DMAEMA).258-261 The surface charge densities (usually greater than 1015 groups/cm2) of
PDMAEMA brushes determine the effect of killing bacteria. The higher charge densities
of the surface attached polymers, the better antimicrobial activities.260 Most PDMAEMA-
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based QA compounds are prepared via the quaternization with alkyl halide, but viologenquaternized PDMAEMA demonstrated significantly increased antimicrobial activity
compared to alkyl halide-quaternized QA compounds due to the enhanced cationic
charged densities.262 Other quaternary ammonium based cationic polymer materials have
been developed in recent years. As a renewable material, rosin based polymers containing
multiple quaternary ammonium compounds have been developed to kill bacteria.257, 263-264
Alkyl pyridinium based polymers are usually prepared based on 4-vinyl pyridine.
Quaternized poly (vinylpyridine) brushes were coated on glass surfaces to kill Grampositive and negative bacteria with an effective charge density from 1012 to 1016
groups/cm2.265 Klibanov and coworkers have developed surface-immobilized N-hexylpoly(vinylpyridine), N-Hexyl,N-methyl-polyethyleneimine (PEI), N-dodecyl,N-methylPEI permanently microbicidal materials.266
Poly(ethylene glycol) (PEG), a hydrophilic polymer, has been used to enhance the
water solubility of materials, and as such, is a significant polymeric material that is
widely-used in bioapplications owing to its unique properties of exceptional
biocompatibility and non-toxicity.267 Surface-coating with PEG can act as antifouling
materials, as it prevents protein absorption and minimizes cell attachment.267-268 Surfaceanchored PEGs have also been reported to prevent protein absorption, enhancing
circulation time, improving tumor targeting, and increasing stabilization in salt
solution.269-275
Temperature-responsive poly(N-isopropylacrylamide) (pNIPAAm) is a unique
polymer that alters its conformation predictably in response to different temperature
ranges. Surface anchored PNIPAAm shrinks and generates pores on nanoparticles
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allowing entrapped antibiotics and biomolecules to be released when the temperature is
raised above the low critical solution temperature (LCST). The polymer swells and closes
the surface pores to inhibit release when the temperature is below the LCST. These
properties can be used to control drug release by adjusting the temperature.276-277
PNIPAAm has a LCST around 32 °C in water, which is perfect for broad applications of
drug delivery278-279 and bio-separations.280-281 Yavuz et al.276 reported the controlled drug
release of pNIPAAm-grafted Au-nanocage by adjusting the near-infrared laser to
generate heat. The monomers NIPAAm and acrylic amide were polymerized by atomtransfer radical polymerization (ATRP) using a disulfide initiator (Figure 1.3).
PDMAEMA is also a significant temperature-responsive polymer with a LCST around 45
°C in aqueous solutions while at pH 8.5. However, the PDMAEMA polymer is also pHresponsive due to the presence of multiple amino groups in its structures. Thus, the LCST
is closely-associated with pH with a LCST of >50°C at pH 7.0 and no LCST at lower
(i.e., acidic) pH.282-283
Since pH responsive polymers usually contain ionizable groups in their structures,
they can be protonated and deprotonated under different pH conditions. Generally, there
are two classes of pH responsive polymers, namely acidic- and basic-polyelectrolyte (i.e.,
polyacids and polybases, respectively). Representatives of polyacids are poly(acrylic
acid) (PAA) and poly(methacrylic acid) (PMAA). Both contain multiple carboxylic acids,
which can be used to chemically- or physically-bind small molecules. Using this
approach, they have been coated on nanoparticles to kill bacteria as antibiotic delivery
materials.176, 212, 284-285 The representative of polybase is PDMAEMA. The main
applications of PDMADEMA are preparing antimicrobial materials via quaternization.
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However, it has also been immobilized on various surfaces for biomedical applications
due to the pH responsive surfaces.219, 286-287

Polymer preparation by controlled radical polymerization
Generally, surface functionalization of nanoparticles with polymers has been
achieved using two methods, namely, “grafting from” and “grafting to” techniques.288
The “grafting from” technique provides a higher surface modification density than
“grafting to” strategy due to the gradually increasing steric hindrance from alreadygrafted polymer chains that occurs in the “grafting to” technique. Controlled/Living
radical polymerization (C/LRP) has been employed in the “grafting from” technique due
to its powerful application in the synthesis of well-defined and advanced structure
polymers, such as block copolymers, branch polymers, and star-shape polymers. Among
all the C/LRP techniques, nitroxide-mediated polymerization (NMP),289 atom-transfer
radical polymerization (ATRP),290-291 and reversible addition-fragmentation chain
transfer polymerization (RAFT)292 have been excessively applied in the complex polymer
structure synthesis.293-298 Surface functionalization of nanoparticles via controlled radical
polymerization generates controlled chain length and polydispersity of polymers on
surfaces.
The first report, to our knowledge, of surface functionalization using ATRP was
in 1997 by Wirth and co-workers.299 Acrylamide was polymerized via ATRP on benzyl
chloride-attached silica surfaces. Then, Matyjaszewski and co-workers significantly
expanded grafting polymers from surfaces via ATRP.291, 300-301 The first report of surface
functionalization using NMP was in 1999 by Hawker and Russell on silicon wafers.302
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Since the invention of RAFT in 1998, it was first used to modify surfaces by Tsuji et al.
in 2001.303 They prepared the RAFT agent in-situ by conversion of a surface-supported
ATRP initiator followed by surface-initiated RAFT polymerization of styrene. Brittain
and co-workers employed azoundecylchlorosilane as an anchor-initiator to commence
RAFT polymerization on silica particles.304 Brittain et al. also employed “click” reaction
to anchor RAFT agents on silica particles to mediate the polymerization of styrene and
methyl methacrylate.305 Benicewicz and colleagues employed a RAFT agent 4cyanopentanoic acid dithiobenzoate (CPDB) to prepare a wide range of polymers from
silica nanoparticle surfaces with a variety of graft densities of 0.01 - 0.68 chains/nm2.284285

Thus, CRP methods have been tremendously important techniques for the “grafting

from” method to prepare polymer grafted nanoparticles.306-309
CRP has also been widely applied in preparing a variety of free polymers, which
are further used in “grafting to” strategies. Both “grafting to” and “grafting from”
strategies have been demonstrated as effective methods to graft polymer brushes on
surfaces, and have been reviewed by Benicewicz,310 Brittain,311 and Matyjaszewski.312-313
Normally, NMP require high reaction temperatures and ATRP generates residue
copper or other metal after polymerization, which is extremely difficult to be completely
removed. Thus, both of NMP and ATRP have not been widely applied on nanoparticle
surfaces for biomedical applications. RAFT, generally employing mild reaction
conditions without residue metal issues after polymerization, is adaptable to a variety of
functional monomers.284, 303, 306, 314-315 Due to the advantage of the RAFT technique, it has
been widely applied for the surface functionalization of nanoparticles with lactose316 and
peptides,317 and to deliver therapeutic agents318 and siRNA.319
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Controlling specificity in targeting bacterial cells
In recent years, and with increasing effort to understand the human microbiome
(i.e. the bacterial communities inhabiting humans), it is now realized that the majority of
bacteria inhabiting humans are non-pathogenic (i.e. commensal), and may even play
essential roles in health.320 Most antibiotics, however, target general bacterial processes
(e.g. cell wall formation, protein translation, DNA replication, etc. See Section 2), so
even relatively ‘narrow-spectrum’ antibiotics have lethal effects on many commensal
forms; which in turn, are thought to negatively affect human health. Therefore, a major
challenge in the future development of antibiotics will be in designing approaches that
target only the pathogenic (i.e. infection-causing) forms, while leaving the majority of
commensal bacteria intact.
One approach for targeting specific bacteria has been the use of antibodies.
Antibodies are produced by the immune response of a mouse, rabbit, or rat,321 and can be
raised against specific proteins (antigens) located on the surface of the bacterium. The
antibody, after purification, is typically conjugated to a fluorophore for detection, and
then used to identify (via its fluorescence) specific bacteria with the antigen signature
amongst a plethora of other species/strains in a complex mixture.
Nanoparticles, when coupled with antibodies, have been used as carrier vehicles
for highly-sensitive biodetection of specific bacterial pathogens.322-324 NP-based
approaches allow single-cell detection because a single NP contains many fluorophore
molecules. Efficient and sensitive detection of bacteria is necessary for maintaining food
quality, and in environmental and biomedical applications. Traditional detection
techniques, such as viable colony counting325 and polymerase chain reaction (PCR) to
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detect pathogen genes, impose a high cost and are time expensive. Comparably,
nanoparticles provide an excellent platform for sensitive and efficient detection because
nanoparticle surfaces can be functionalized and quickly modified with specific antibodies
to recognize biomarkers on bacteria.
The relatively large size (ca. 150 kDa) of many antibodies limits their ability to
disperse under many biological conditions, especially when conjugated to nanoparticles.
Antibodies are Y-shaped glycoprotein molecules, and consist of both a framework (FR)
and hypervariable (HV) region. The tail of the HV region provides the antibody with
specificity for the binding antigen (i.e. the binding domain). A small section of this tail
(containing the binding domain) has been used to facilitate the development of 13 kDa
single-domain antibodies (sdAbs) that can be conjugated to quantum dots (QD) (<12 nm
dia.). The sdAbs can be conjugated to QDs in a highly-oriented manner to enhance
binding efficiency and be used as ultra-small diagnostic nanoprobes.324, 326-327 In general,
antibody conjugated-nanoparticles have been used for highly sensitive detection of
specific species within a complex mixture of bacteria.322, 328-331
Antibody conjugated-nanoparticles can also be designed as multifunctional
platforms for targeted bacterial detection and destruction. When nanoparticles are
equipped with magnetic properties (as discussed above), then conjugated with antibodies,
they can be used for detection and/or separation of specific bacteria from a mixture of
species.323, 329, 332 For example, antibody conjugated-magnetic nanoparticles, can separate
the bacteria E. coli and Salmonella typhimurium,333 and allows a detection limit of 104105 cells/mL. Magnetic nanoparticles have also been applied as sensors to enhance
interactions between vancomycin coatings on nanoparticles and D-alanyl-D-alanine in
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bacterial cells, with a corresponding detection limit of 103 cells/mL. The antimicrobial
enzyme lysostaphin was adsorbed on the surface of antibody conjugated-nanoparticles
specific to the bacterium Staphylococcus aureus.334 Lysostaphin hydrolyzes the
peptidoglycan linkages in the cell wall to lyse and kill the bacterium.
The unique size effect and emerging surface functionalization toolboxes make
nanoparticles an excellent platform to efficiently and sensitively detect bacteria. As
discussed earlier in this review (see Section 4.1), the surfaces of nanoparticles can be
engineered with RAFTs at finely-controlled densities to tailor the accessibility of the
conjugated moieties on the RAFTs. In this way, several different antibiotics can
potentially be delivered by a single nanoparticle. This approach offers an exciting
potential to increase the specificity of an antibiotic attack and to reduce destruction of
helpful bacteria by antibiotics.
Finally, in order for nanoparticle-based approaches to operate efficiently, the
nanoparticle-carrier must either penetrate the bacterial cell (as discussed below), or
release its cargo at the cell surface. Approaches for the controlled release of conjugated
molecules from nanoparticles has been developed using both pH-sensitive and infraredsensitive ligands.

Entry of nanoparticles into the cell
Certain antibiotics, owing to their mechanism of action, require entry into the
cytoplasm in order to kill or inhibit bacterial cells. Together, the cell membrane(s) and
cell wall provide a protective barrier that restricts the movement of molecules and ions
into and out of the cell, as well as maintains the structural stability of the cell.335 As
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mentioned earlier, the outer membrane (OM) forms the outermost boundary with the
extracellular environment of Gram-negative bacteria, while the cell wall accomplishes
this in Gram-positive species (Figure 1.1). The OM and inner (plasma) membranes (IM)
selectively allow smaller molecules ( <600 Da) to diffuse through the lipid bilayer while
preventing macromolecules larger than 1 kDa336 from permeating the membrane without
active transport.
Many studies have shown that the interaction of some metallic nanoparticles with
bacteria results in cell lysis (and death).188, 337-338 In these studies, the nanoparticles used
were relatively toxic and included ZnO, CuO, Ag, TiO2, and Al2O3. In some cases,
nanoparticles were observed within lysed cells, suggesting that the nanoparticles were
taken up by cells and cell death occurred either during or shortly after uptake.
It is now realized, however, that bacteria may also take up very small particles
into their cellular cytoplasm, without apparent lethal effects. For example, quantum dots
(<10 nm diameter) were shown to be taken up via a purine-dependent mechanism.339
Also, 10 nm diameter gold colloids have been shown to enter viable cells during the
uptake of large proteins.340 Although examples exist, particle uptake by bacteria is
contrary to our current understanding, and is not well understood. Very few studies have
noted either direct or indirect uptake.
In order for non-lethal particle uptake to occur, the process will likely require
active transport, and the ability of the bacterium to hydrolyze a small portion of the cell
wall, and then reform the wall without significant loss of intracellular contents. The
interior of a bacterial cell, however, has a high turgor pressure relative to the immediate
outside environment. Successful entry into a bacterium without cell death presupposes
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that the particle can cross through the cell membrane(s) and cell wall without lysis and
significant loss of intracellular contents. How this might occur is currently unknown.
Some insight can be gained from the examination of the uptake of
macromolecules into larger eukaryote cells.341-342 This process, called endocytosis,
utilizes membrane vesicles to shuttle extracellular materials into the cell. There are two
methods of endocytosis, classified as phagocytosis or pinocytosis.343-344 Pinocytosis
includes macropinocytosis, clathrin-mediated endocytosis, and caveolae-mediated
endocytosis, as shown in the Figure 1.4 and Table 1.1.345-346 These endocytosis pathways
differ from each in the nature of the internalized materials, the size of vesicles, the type of
cells, and the kinetics of the uptake process.345 However, endocytotic-like uptake by
bacteria has only been shown in one case, 340 and is not well understood at present.
Nanoparticles provide an excellent carrier to transport drugs347 and siRNA348 to
the cytosol by endocytosis in eukaryote cells. Without the nanoparticle carrier, these
molecules would not be able to diffuse through the lipid bilayer.
The interaction between nanoparticles and the cell membrane can be influenced
by the size, shape, surface charges, and surface functional groups of nanoparticles. For
example, Chithrani et al. reported that 50-nm Au nanoparticles were more efficiently
taken up by eukaryotic HeLa cells than 14-nm and 74-nm size Au nanoparticles.347-348
Spherical nanoparticles346 were reported to be internalized 500% more than rod-shape
nanoparticles in eukaryotes. The nanoparticles size and shape have been reported to
influence the binding of receptors on the cell membrane.349 The surface coating on
nanoparticles can be designed to inhibit protein absorption and minimize nonspecific
interactions with cell membranes. For example, neutral ligands such as poly(ethylene
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glycol) (PEG) and zwitterions have been used to reduce inefficient targeting and potential
agglomeration of nanoparticles at the cell surface.350-352 Nanoparticles with surface
negative charge moieties have been reported to have poor interactions with the cell
membrane, which leads to very limited internalization.211, 353-354 In contrast, cationic
nanoparticles have been widely demonstrated to bind with negative moieties on cell
membranes and thus facilitate the movement of substrates across the lipid bilayer.355 The
mechanism of interaction between cationic nanoparticles and cell membranes was
confirmed by AFM investigation,356 and showed that the positive moieties destabilize the
membrane and cause the formation of pores in defective areas of the membrane. Thus, in
eukaryote cells, the size, shape, surface charges, and surface functional groups of
nanoparticles can influence the interaction between nanoparticles and the cell membrane.
These factors will prove important when targeting intracellular bacterial pathogens.

Drug loading
In order to address drug delivery approaches to bacteria, it is useful to examine
the techniques used to engineer nanoparticles for drug delivery. Generally, the two basic
approaches used to attach drugs to nanoparticles include covalent and non-covalent
binding. Both approaches possess specific advantages and disadvantages. Covalent
binding offers a steady delivery platform, but usually requires pre-treatment of drugs. For
example, Cheng and colleagues reported the synthesis of phthalocyanine-based
photodynamic therapy (PDT) using drugs conjugated to gold nanoparticles.357 The drug
release and PDT efficacy are affected by the chemical bond between the drug molecules
and the Au surface. Specifically, the labile amino adsorption triggers the drug release into
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HeLa cancer cells. In another study, Gu and co-workers reported the synthesis and
improved activity of vancomycin-conjugated Au nanoparticles against vancomycinresistant Enterococci (VRE) and Gram-negative bacteria.137 Covalent binding between
drugs and nanoparticles provides a secure method of binding that lessens drug pre-release
or leakage. Covalent binding also allows for the drug release speed to be controlled by
adjusting the breakage rate of the covalent bond. Usually, slow release drug delivery
strategies employ the covalent binding method.
In non-covalent binding strategies, potential drug pre-release or leakage can be
avoided by using stimulus functionalities on the nanoparticle shell to block or cover the
drug releasing pores. Baeza and co-workers reported the preparation of
poly(ethyleneimine)-b-poly(N-isopropylacrylamide) (PEI/NIPAM) coated mesoporous
silica nanoparticles (MSN) with encapsulated iron oxide nanocrystals to deliver multiple
drugs simultaneously (Figure 1.5).184 The grafted block copolymer was designed to retain
the drugs inside the NP through temperature-responsive control and by attaching proteins
into the grafted polymer shell via intermolecular interactions. The use of specific
functionalities to block nanoparticle pores is an efficient method to prevent drug preleakage. Non-covalent binding provides a straight forward method for drug delivery and
the decreases the risk of drug pre-leakage.
In addition to drug entrapment, other barriers have been designed to minimize
drug pre-leakage in non-covalently bound nanoparticles. Chen et al. reported a new
magnetic drug delivery system that utilizes doxorubicin (DOX)-associated Fe3O4
nanoparticles coated with a polyethylene glycol (PEG) modified porous silica shell
(Fe3O4-DOX/pSiO2–PEG) to treat tumors.358 The DOX-conjugated Fe3O4 nanoparticles
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were embedded in a silica shell and coated with PEG chains (Figure 1.6). After etching
the thick silica shell, the Fe3O4-DOX/pSiO2–PEG was 150 nm in diameter. The porous
silica shell presents a physical obstacle that decreases the dissociation rate of DOX from
the nanoparticle core.
Like covalent binding, non-covalent binding provides a direct loading and release
mechanism. However, drug pre-release or non-specific leakage is frequently noted. To
counteract this problem, Mortera and co-workers prepared a mesoporous silica
nanoparticle-based cage-like vehicle to deliver cysteine intracellularly.178 The cysteine
was encapsulated within the nanoparticle and only released when triggered by
intracellular antioxidants. Similarly, Adeli et al. prepared a hybrid nanostructure with a
gold core and a polyrotaxane shell.359 Both cisplatin and DOX were associated with the
hybrid nanoparticles, and drug release controlled by photothermal explosion. Similarly,
Rotello and co-workers reported the synthesis of monolayer-functionalized gold
nanoparticles with a hydrophobic alkane thiol core and a hydrophilic shell.185 The
hydrophilic shell consisted of a tetra (ethylene glycol) (TEG) component, end-capped
with a zwitterionic group. Hydrophobic drugs were entrapped in the hydrophobic region
of the nanoparticle surface monolayer via nonspecific binding and released into cancer
cells by membrane-induced diffusion.

Controlled drug release
A variety of release strategies of nanoparticle drug delivery vehicles have been
reported, and are controlled by pH, light, temperature, enzymes, or magnetic fields.179, 185,
357, 360-363

The drug release strategies are directly dependent on the drug binding methods.
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For those carriers with covalent binding between nanoparticles and drugs, a low pH
solution will hydrolyze the covalent bond. For example, Zhang and co-workers prepared
doxorubicin conjugated Fe3O4 encapsulated in thermo-responsive dextran-g-poly(Nisopropylacrylamide-co-N,N-dimethylacrylamide) and that conjugated to a 3mercaptopropionic acid hydrazide-functionalized nanoparticle via an acid-labile
hydrazone bond (Figure 1.7).364 At a temperature above the lower critical solution
temperature (LCST), drug release was controlled in a mild buffer solution. Alternatively,
UV (256 nm) and visible (530 nm) light was used to switch the confirmation of the
polypeptide backbone of diarylethene-containing cyclic peptidomimics.365 Enhanced
antimicrobial activity was seen with the ‘open’ form of the compound, and completely
lost in the ‘closed’ form.
Carriers that are pH-responsive also provide a controlled drug release for noncovalently bound nanoparticle and drugs. He and co-workers reported a one-pot selfassembly strategy to prepare a MSN-based drug delivery vehicle whose release is
stimulated by pH change (Figure 1.8).366
Magnetic field, temperature, and light were used to stimulate the drug release
from their corresponding vehicles. McGill and co-workers reported that magnetic
nanoparticles can disrupt a viscous extracellular biopolymer under a low oscillating
magnetic field (OMF) of 295-kHz and enhance the delivery of lambda DNA/HindIII.367
The OMF induced thermal activity of the nanoparticle can enhance its transportation in a
viscous environment, as well as induce the breakage of DNA to trigger drug release.
Urbina and co-workers prepared magnetite- poly(methylmethacrylate) (PMMA) and
cobalt –PMMA nanoparticles with ﬂuorescein isothiocyanate (FITC), and tested drug
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release with magnetic and thermal control.368 Ren and co-workers reported the
modification of Au (shell) - Au2S (core) nanoparticle surface with 11mercaptoundecanoic acid (MUA) to load the anti-tumor drug cis-platin.369 The loading of
drug onto Au - Au2S nanoparticles was pH-dependent and the drug release was triggered
by near-infrared irradiation, which is not harmful to human tissues.

1.5 OVERCOMING THE BACTERIAL BARRIERS OF INFECTIONS:
NANOPARTICLES AS ANTIMICROBIAL DELIVERY VEHICLES
Using NPs as antimicrobial delivery vehicles (ADVs) offers an extraordinary
potential to control bacterial infections. Most bacterial infections occur as attached
biofilms, where cells are embedded within a protective matrix of extracellular polymers
(EPS) that are secreted by the bacteria.370 Nanoparticles have shown a strong ability to
complex to biofilms, and more specifically the EPS matrix of biofilms, both in natural
environments371-372 and under laboratory conditions.373-374 In order to treat biofilm-based
infections with NPs, their physical and chemical properties, primarily size and surface
chemistry, must be designed to overcome several major hurdles within a biofilm. First,
NPs must be able to penetrate the EPS matrix in order to reach and destroy the cells
enveloped within a biofilm. The NP size will limit its ability to diffuse through the EPS,
while the NP surface properties will dictate the amount of interaction between the EPS
polymers and the NPs. Therefore, in order to inhibit a biofilm infection, the corona
surrounding a NP must be tailored to facilitate diffusion through the biofilm EPS to
resident bacterial cells.375 Although there is little research in this area, it has been noted
that diffusion of NPs through biofilms is affected by the viscosity of the EPS, the
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variability of cell density, the bulk fluid flow of water, and the external mass transfer
resistance (stagnant liquid layer on surface of biofilm that slows penetration of solutes) in
three dimensions. However, the movement of nanoparticles through EPS is a poorly
understood phenomenon. This section will discuss how NPs are impacted by these
factors, as related to bacterial biofilms

The biofilm state: a primary hurdle for infection control
Many bacteria are now realized to occur as attached structured communities
called biofilms, where cells are surrounded by a secreted matrix of extracellular
polymeric substances (EPS).370, 376 Biofilms have been recognized to play a major role in
human health over the past 50 years, as the occurrence of bacterial infections has shifted
from acute infections, such as cholera and diphtheria, to chronic infections, such as
MRSA and Pseudomonas aeruginosa. Chronic bacterial infections are generally found in
the biofilm state, allowing them to evade the immune system and persist through
antibiotic treatment.377 Such biofilm-based diseases are common and include infectious
kidney stones, bacterial endocarditis, cystic fibrosis airway infections, periodontitis, and
indwelling medical device infections.378-379 A major difficulty in treating chronic
bacterial infections lies in the biofilm matrix (i.e. EPS) in which the bacteria reside.
Antibiotics that are able to eliminate planktonic forms of bacteria may require 100- to
1000-fold higher concentrations to defy the heterogeneous complexity of a biofilm
matrix, and even then the infection often will persist. Biofilm-associated cells possess a
number of special adaptations, collectively called ‘insurance effects’, which serve to
enhance their survival and persistence against stressors such as antibiotics.380
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As seen in Figure 1.9, the biofilm matrix provides nutrients, protection, and
hydration to a dense community of bacteria. A significant amount of research has been
devoted to understanding the role and development of the biofilm matrix (for a thorough
review, see Flemming & Wingender).376 In response to environmental conditions, the
integrity and function of the biofilm changes to ensure survival and persistence of the
bacteria. The complexity of the matrix is due to its many components, which include
proteins, lipids, polysaccharides, glycoproteins, glycolipids, membrane vesicles, nucleic
acids, ions, and, of greatest abundance, water.382 EPS also contains many sorption sites383
for potential interactions with nanoparticles and charged molecules. The plasticity of the
biofilm matrix allows it to fulfill the roles of protector, electron donor/acceptor, anchor,
and retainer of nutrients, enzymes, energy, and genetic material under dynamic
conditions.376 A recent study has suggested that the EPS of the biofilm matrix contributes
to an osmotic gradient in the matrix and drives biofilm spreading.384 In addition to a
complex composition, biofilms also exhibit heterogeneity in bacterial species and gene
expression.370, 385
While occasionally biofilms can consist of a clonal population of one bacterial
species, they most often occur as a population of many, diverse bacterial species.386
Under both circumstances, gene expression varies throughout the biofilm in response to
environmental conditions, resulting in localized areas of specific cell activity.387 For
example, the bacterium P. aeruginosa modifies gene expression to control alginate
production and motility in response to biofilm aggregation.388 Even within the EPS itself
there is much heterogeneity in its physical structure389 owing to the existence of
microdomains,390-391 which may contribute to diffusive transfer. Specific extracellular
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polysaccharides (e.g. PsI) are now related to attachment and biofilm formation in P.
aeruginosa.392-393 Similarly, Staphylococcus aureus has been shown to regulate key
structural biofilm components via gene regulation throughout biofilm development.394
The ability to display multiple spatiotemporal phenotypes throughout biofilm formation
is a survival technique used by bacteria to colonize surfaces and establish an infection.
The microenvironment created by the gradient of matrix components throughout the
biofilm allows bacterial cells to thrive and persist under adverse conditions once the
biofilm has been established. An excellent review of biofilm initiation and development
is provided by Hall-Stoodley et al.370

Challenges for inhibition of biofilms using engineered nanoparticles
It is reasonable to assume that diffusion is a requirement for substantial biofilm
growth (i.e. how else can nutrients (to cells) and wastes (from cells) move within a
biofilm?). Using time-lapsed confocal scanning laser microscopy, the time of penetration
for a 10 kDa molecule to reach the center of a cell cluster was estimated to be 3
minutes.395 The inherent complexity of a bacterial biofilm makes it easy to underestimate
nanoparticle mobility and difficult to standardize diffusion coefficients. Diffusion models
must consider the 1) viscosity of the EPS, 2) the variability of cell density, 3) the bulk
fluid flow of water, 4) interactions of the solute with the EPS (i.e. diffusion reaction
constraints), 5) the sizes (and volumes) of water spaces between EPS molecules, and 6)
the external mass transfer resistance (stagnant liquid on top layer of biofilm that slows
penetration of solutes) in three dimensions.
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The EPS matrix hurdle: a physical barrier to nanoparticle diffusion
Both simple and complex models have been developed to determine the rate at
which molecules and/or nanoparticles of a particular size can permeate through and
diffuse within a biofilm of a particular viscosity and composition.396-398 The rapidly
developing field of nanotechnology offers an alternative method to treating biofilm
infections, and functionalized nanoparticles have the potential to efficiently deliver
antimicrobial compounds to microbial cells within a biofilm.
Diffusion through the EPS matrix is a complex process. Currently, it is thought
that small molecules diffuse through both pure water and EPS at approximately the same
rate. The EPS matrix consists of mostly free water that is immobilized within pore spaces
between a framework of polymeric molecules.399-400 Given that small molecules and
nanoparticles often move freely through the water, the limiting factor in their movement
through biofilms is directly related to interactions with the EPS matrix polymers. Many
diffusion rates of small molecules have been measured in various types of biofilms with
values ranging from 0.9 to 0.2, when compared with diffusion through pure water.401-405
Using our knowledge of small molecules in biofilms, the movement of nanoparticles in
biofilms can be studied.
Currently, a key criterion in the design of nanoparticles intended to penetrate a
bacterial biofilm is the size and charge of the nanoparticle. Recent studies have shown
that nanoparticles are able to diffuse through a biofilm; however, the rate of diffusion has
been directly related to the size of the nanoparticle.395-398, 401, 403, 406-410 As such, a final
hurdle involves the design of nanoparticle size and surface properties that will facilitate
their penetration into a biofilm matrix.
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Several publications have suggested that the connectivity and size of pores within
a biofilm influences the speed and penetration of nanoparticles. Hindrances such as a
porous biofilm, local accumulation of nanoparticles on bacterial cells and large
macromolecules, the nonspecific adsorption of nanoparticles to freely diffusing species,
abiotic particles, and gas all play a role in preventing efficient diffusion of
nanoparticles.397 Studies have been conducted to show that larger nanoparticles diffuse
slower through biofilms because they get trapped in pores, cell aggregates, and the
general biofilm matrix more than their smaller counterparts.406-407 Peulen et al.
demonstrated that 57 nm, 92 nm, and 135 nm nanoparticles had little success with
penetration in a dense biofilm.397 They concluded that the effective pore size in loose
biofilms is approximately 50 nm, which translates to efficient diffusion for nanoparticles
near 10 nm in diameter. Hidalgo et al. showed that nanoparticles of up to 70 nm could
penetrate a bacterial biofilm; however, they also showed that nanoparticles measuring
less than 30 nm were most effective at homogenously filtering through the matrix.409
Steric hindrance by the biofilm matrix does not play a major role in nanoparticle
diffusion, and therefore does not influence the rate at which nanoparticles diffuse through
a biofilm.403 Currently, a key criterion for designing nanoparticles that will effectively
penetrate and target bacterial cells within a heterogeneous biofilm will be size
manipulation.

Enhanced antibiotic resistance in biofilms: physiological and genetic
The phenotypic, genotypic, and physical complexities of a bacterial biofilm
present many challenges to modern medicine. In general, bacterial antibiotic resistance
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occurs as a consequence of genetic mutation, acquisition of antibiotic resistance genes,
and/or horizontal gene transfer.411-412 Antibiotic resistance and antibiotic resistance genes
have been present in bacterial genomes throughout their evolution. A study from 2004
showed that serine -lactamase (an enzyme capable of inactivating -lactam antibiotics)
genes originated nearly 2 billion years ago, and have been present on plasmids for
millions of years.413 Most antibiotic producing organisms carry genes that encode
antibiotic resistance to ensure self-protection;414-415 such genes are usually found in the
same gene cluster as the antibiotic synthesis genes.416-417 A thorough review of the
presence and role of antibiotic resistance genes in natural environments is provided by
Allen et al.418
In addition to genomic manipulations, mechanisms of antibiotic resistance within
a biofilm are also related to restricted antibiotic penetration,419-423 decreased bacterial
growth rates and metabolism,423-426 quorum sensing and induction of a biofilm-specific
phenotype,172 induction of stress response genes,427-428 and an increase in the expression
of efflux pumps. These mechanisms are referred to as non-inherited resistance, and are
intrinsic phenotypic characteristics of bacteria in a biofilm or structural obstructions of
the biofilm matrix.411, 429-430 A detailed analysis of antibiotic resistance in biofilms has
been reviewed by Høiby et al.431
Kirby et al. developed a method to assess the contribution of the physical
structure to the phenotypic resistance of biofilms, without genetic or chemical methods
that could be confounded by pleiotropic effects.429 Their study demonstrated that during
high cell densities, planktonic cultures exhibited similar levels of antibiotic resistance as
biofilm cells; however, the cells released from biofilms were individually more
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susceptible to antibiotics that target the cell membrane components (colistin) or depend
on membrane function for uptake (gentamicin, streptomycin) than their planktonic
counterparts. They suggest that the cell membrane of biofilm bacteria may be more
sensitive to antibiotics than the cell membranes of planktonic bacteria. Their results
indicate the both cell membrane physiology and the structure of the EPS matrix plays a
role in antibiotic resistance within biofilms.
The diverse nature of biofilms also enhances resistance to antibiotics, as seen
when mixed biofilms of Candida albicans and S. aureus more effectively resist
vancomycin than either as mono-biofilms or mono-planktonic cultures.432 Social
interactions are essential for successful multicellular complexity.433 The ability of
bacteria to interact within a biofilm allows the cells to maintain a more-stable
environment that confers antibiotic resistance via horizontal gene transfer,434-435 the
sharing of common resources,436-437 and the regulation of core sets of genes.438 The
physiological heterogeneity of a bacterial biofilm makes it extremely pliant and
adaptable, and incredibly difficult to combat and eliminate. However, this complexity
also offers a variety of targets for researchers to exploit.
A recent review by Yang et al. discussed current approaches that are used to
eliminate bacterial biofilms.439 The review focused on biochemical approaches such as
antimicrobial agents and peptides, physiochemical approaches such as modifying
industrial surfaces with anti-adhesive and microbicidal agents, biological approaches
such as inhibiting biofilm formation with the use of natural products found in mixed
culture biofilms, and approaches that directly interfere with structural development and
differentiation within a biofilm such as eliminating EPS production or inhibiting the
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ability of bacteria to socially interact via quorum sensing inhibition. In an effort to
combine these many approaches, the development of functionalized nanoparticles has
been investigated.
While the formulation of nanoparticles is well established and continues to be
improved upon, their applications to target bacteria and the exact mechanisms of action
are less well understood. A recent study by Decho, Benicewicz, and colleagues found that
when complexed to SiO2 nanoparticles, the common antibiotic penicillin-G is effective in
killing penicillin-resistant strains of bacterial pathogens, including strains of methicillin
resistant Staphylococcus aureus (MRSA), at low total concentrations.440 The authors
termed this effect the ‘grenade hypothesis’ and postulated that each nanoparticle delivers
a concentrated package of antibiotic to a given cells, perhaps overwhelming its resistance
mechanism (e.g. beta-lactamase enzymes), which are normally used in defense against
the antibiotic. While this hypothesis remains to be confirmed, the use of nanoparticles as
antibiotic-delivery vehicles (ADVs) is an emerging area of exploration.

1.6 CONCLUSION
Nanoparticle-based delivery of antibiotics is being proposed, and developed, as a highlyefficient means to deliver antibiotics and target bacterial infections. It offers the
possibility to deliver high concentrations of antibiotics, and thus overwhelm bacterial
antibiotic resistance strategies. The future efficacy of nanoparticle-based delivery of
antibiotics rests upon the ability of nanoparticles to localize a high-concentration of
drugs, reach a pre-determined target with high specificity and efficiency, and release
those drugs in a controlled and timely manner without toxic effects to in vivo host cells.
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Table 1.1 Description of major endocytosis pathways. Reprinted with permission.346

Figure 1.1 Diagram of cell walls of Gram-positive and Gram-negative bacteria.19
Download for free at http://cnx.org/contents/9e7c7540-5794-4c31-917dfce7e50ea6dd@11@11.
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Figure 1.2 A schematic illustration showing the loading and release mechanism of an
anionic drug in TA modified MSN (a) Before the drug is adsorbed, (b) after drug
adsorption, (c) electrostatic repulsion triggering drug release, and (d) ion-exchange
triggered drug release. Reprinted with permission.210
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Figure 1.3 (a) A schematic illustration showing the controlled drug release of a
pNIPAAm-grafted Au nanocage by adjusting a near-infrared laser to generate heat and
release the entrapped contents; (b) Atom-transfer radical polymerization (ATRP) of
NIPAAm and acrylic amide (AAm) monomers. Reprinted with permission.276
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Figure 1.4 Major endocytosis pathways. Reprinted with permission.345

Figure 1.5 The schematic illustration of multidrug release by MSN-polymer
nanocomposite. Reprinted with permission.184
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Figure 1.6 The schematic illustration of the synthesis of DOX-associated Fe3O4
nanoparticles coated with a PEG modified porous silica shell. Reprinted with
permission.358
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Figure 1.7 The schematic illustration of the synthesis of core-shell drug delivery vehicle.
Reprinted with permission.364

Figure 1.8 A schematic illustration showing the one-pot self-assembly strategy for
synthesis of drugs@micelles@MSNs. Reprinted with permission.366
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Figure 1.9 A biofilm is composed of attached microbial cells encased within a matrix of
extracellular polymeric secretions (EPS), which surround and protect cells. The EPS
matrix is typically composed of polysaccharides, proteins, lipids, and extracellular DNA
(eDNA). Localized within the EPS matrix (see figure inset) are extracellular enzymes (eEnzymes). Also present are small pieces of DNA carrying specific genes, called
plasmids. Both e-Enzymes and plasmids are protected against degradation with the
biofilm. Finally, bacteria release signal molecules for a process of chemical
communication called quorum sensing. A biofilm may extend from just a few to
hundreds of micrometers above a surface, but is equipped with many inherent adaptations
that are not present in planktonic cells. Reprinted with permission.381
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CHAPTER 2
FUNCTIONALIZED NANOPARTICLES SILENCE BACTERIAL COMMUNICATION

Excessive use of antibiotics has resulted in an increased rate of bacterial resistance and
poses a significant public health threat. As a result, non-cytotoxic methods of controlling
bacterial infections, such as interference in bacterial communication (i.e. quorum
sensing), are necessary to avoid resistance against antimicrobial therapies.441 Quorum
sensing (QS) is a chemical signaling scheme used by bacteria to communicate and
coordinate their activities within a biofilm. Figure 2.1 displays a common structure of a
chemical signal used by bacteria during communication. QS regulates the features that
make bacteria dangerous, such as biofilm formation, virulence factor production, and
uptake of antibiotic resistant genes.431, 442-443
The goal of this chapter was to develop functionalized nanoparticles that will
weaken the communication network of bacteria, rather than target the viability of cells, in
order to fight pathogenic infections while limiting the risk of antibiotic resistance. To
accomplish this I used functionalized silicon dioxide nanoparticles (Si-NPs) to quench
the small, diffusible signal molecules (e.g. Figure 2.1) that bacteria rely on to
communicate and coordinate their activities. The functionalized Si-NPs are added to
bacterial cultures and bind the chemical signals as they diffuse between cells.
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Sequestering these signals via functionalized nanoparticles and subsequently blocking
bacterial communication can potentially prevent activities such as pathogenesis,
adhesion, and biofilm formation. This chapter describes the growth and transcription
studies used to demonstrate that this anti-virulence technology controls bacterial
infections by directly influencing bacterial communication and subsequent activities
regulated by quorum sensing.
Inspired by developments in the field of drug delivery, nanoparticles have been
designed to carry compounds that will quench signal molecules. Removal of signals from
the immediate bacterial environment prevents the molecule from reaching its cognate
receptor, thus inhibiting the signal/receptor interaction, and interfering with down-stream
regulation. In theory, this process will quench signal molecules and “turn off” quorum
sensing and silence bacterial communication. -cyclodextrin (-CD) is a compound that
nonspecifically binds N-acyl-L-homoserine lactone molecules,444-445 a common class of
signal molecules produced by Gram-negative bacteria. -CD consists of seven
glucopyranose units bound by -1,4-glycosidic linkages (Figure 2.2).
This molecule takes the shape of a truncated cone with a hydrophilic exterior and
a slightly hydrophobic interior. -CD was chosen as a model compound because the
formation of a CD complex can often be detected and because the reactivity of a guest
molecule in a CD complex is often modified.446 In many cases, the CD accelerates the
various reactions associated with the guest molecule and modifies the reaction pathway.
Herein we present a new approach to disrupting bacterial quorum sensing with silicon
dioxide nanoparticles that have been surface-functionalized with -CDs.
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2.1 CHARACTERIZATION OF MONOLAYER NANOPARTICLES
The unique properties of surface-functionalized nanoparticles make them ideal for
targeting the multiple avenues of bacterial defenses and weakening an infection. Surface
functionalization plays a critical role in tailoring the properties of nanoparticles via welldeveloped surface chemistry.254, 447 A method has recently been developed for the
synthesis of carboxylic acid-coated silicon dioxide nanoparticles with a controllable
functionalized surface.284-285 Using this method, monolayer -CD coated fluorescent
silicon dioxide nanoparticles were synthesized via a coupling reaction between the
hydroxyl groups of -CD and a monolayer dye-labeled carboxylic acid coated silicon
dioxide nanoparticle. A representation is seen in Figure 2.3.
The carboxylic acid coated nanoparticles were prepared based on a ring opening
reaction between succinic anhydride and amino-functionalized silica nanoparticles with a
variety of surface graft densities ranging from 0.24-0.65 groups/nm2. Thus, the graft
density of -CD functionalized nanoparticles can be tailored by varying the feed ratio
between bare silica nanoparticles and amino-silane compound. The as-synthesized -CD
functionalized nanoparticles were purified via dialysis to remove un-reacted free -CD
molecules, as confirmed by 1H NMR (Figure 2.4). Additionally, thermogravimetric
analysis (TGA) confirmed that the monolayer -CD accounted for 2.78% of the total
weight for particles having a surface graft density of 0.24 groups/nm2 (Figure 2.5). The
core diameter of the nanoparticles was either 15 nm or 50 nm.
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2.2 CHARACTERIZATION OF POLYMER NANOPARTICLES
In addition to monolayer -CD coated nanoparticles, polymer coated
nanoparticles were also tested. Polymer grafted silica nanoparticles containing -CD side
groups were prepared via the condensation reaction between the grafted poly(methacrylic
acid) and the hydroxyl groups on -CD. A schematic representation is seen in Figure 2.6.
The dye-labeled poly(methacrylic acid) grafted silica nanoparticles were prepared
by direct surface-initiated RAFT polymerization of methacrylic acid on dye-labeled silica
nanoparticles. Thus, the carboxylic acid loading can be controlled by tailoring the surface
grafted poly(methacrylic acid) brushes length as well as the graft densities. TGA data
showed that the surface polymer supported chains with multiple -CD accounted for
61.7% by weight for particles that have a PMAA brush density of 0.18 chains/nm2 and
molecular weight of 54,900 mol/g (Figure 2.7). The -CD side chain based polymer
grafted nanoparticles showed strong fluorescence under UV light, even after multiplestep surface chemical modifications (Figure 2.8).

2.3 NMR DETECTS BINDING OF HSLS AND -CYCLODEXTRIN
The NMR diffusion measurements were used to provide insight into the binding
of N-octanoyl-L-homoserine lactone (C8-HSL) to both -cyclodextrin and cyclodextrin. The data for various concentrations of C8-HSL and CD are summarized in
Table 2.1. The observed diffusion coefficients (D) are the average values that were
determined for each 1H resonance arising from the two compounds. While the D of the
cyclodextrins in each solution remains unchanged (within experimental error), the D of
C8-HSL decreases towards the D of CD as the ratio of CD to HSL is increased. In the
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case of a large excess of CD, the equilibrium of C8-HSL shifts to the bound form and the
D of C8-HSL is the same as the CD. This indicates that all of the C8-HSL is in the bound
form.
It is important to note that NMR diffusion data for the HSL can be fit with a
single exponential function and there is no evidence of two diffusing forms, i.e., free and
bound. Therefore, the data suggests that during the timeframe of the NMR experiments
(100s msec) the HSL is rapidly moving between free solution and bound into the CD and
an equilibrium of the two forms exists.
The observed diffusion coefficient (Do) for the C8-HSL in these mixtures is a
weighted average between the free diffusion coefficient (Df) and that of the bound from
(Db)448

Do = Ff Df + Fb Db

(1)

where Ff is the fraction of C8-HSL that is free and Fb is the fraction that is bound. The
dissociation constant can be calculated from the measured diffusion coefficient and the
starting concentrations of the two species by:

Db – Do

Do – Db
(2)

Kd =

[CD]

Do – Df

+ [C8-HSL]

Db – Df

Since diffusion coefficients are sensitive to variations of temperature and sample
viscosity, comparisons across samples are difficult. However, the observed diffusion
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coefficients (Do) can be corrected using the diffusion of water in each sample and
comparing that to a standard value. For this study we corrected each Do with that of the
H2O measured in the solution of only C8-HSL.

DCorr = Do DH2O / DH2O-C8-HSL

(3)

The calculated values of Kd for each of the solution are included in Table 2.1. The
three values for the -CD are in close agreement with each other (average = 1.50 x 10-3
M). This value is 7.5 times higher than that of the -CD. Expressed differently, C8-HSL
binds 7.5 times stronger in the -CD than the -CD (Ka = 1/Kd). The smaller interior of
the -CD is a better fit for the C8-HSL. This procedure was also used to determine the
diffusion coefficient for 3OC6-HSL and -CD; however, initial attempts were
unsuccessful and did not indicate binding.
The binding strength between -CD and HSLs was determined, although -CD
was strictly used as a model binding agent and will eventually be replaced with a highlyspecific compound. NMR diffusion experiments demonstrated that both C8-HSL
(produced by V. fischeri) and C6-HSL (produced by Pseudomonas aeruginosa) could
bind to -CD in a 1:1 ratio; however, there was no evidence that 3OC6-HSL (also
produced by V. fischeri) formed a complex with -CD. Further calculations revealed the
binding and dissociation constants of the experimental complexes. As seen in Table 2.2,
there was weak binding between the HSLs and -CD with 17% of C6-HSL and 35% of
C8-HSL bound to -CD at any one time in the 1:1 solution. After demonstrating that the
formation of a -CD/HSL complex was possible, we sought to quantify the quenching
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ability of -CD in vitro. Using growth and luminescence studies we observed the
influence of -CD on V. fischeri bioluminescence.

2.4 -CYCLODEXTRIN QUENCHES HSLS IN VITRO
To test the quorum quenching function of these nanoparticles, the marine
bacterium Vibrio fischeri was employed as a model. V. fischeri relies on N-acyl-Lhomoserine lactone molecules to trigger coordinated activities such as colonization and
bioluminescence in a threshold dependent manner.449 Specifically, V. fischeri synthesizes
and responds to N-3-oxo-hexanoyl-L-homoserine lactone (3OC6-HSL)450-451 and Noctanoyl-L-homoserine lactone (C8-HSL) (Figure 2.9)452 via the lux operon, which is also
responsible for the proteins that synthesize luminescent luciferase.453 This quorum
sensing function allows V. fischeri to establish a symbiotic relationship with the
Hawaiian bobtail squid (Euprymna scolopes) in their natural ocean habitat.454
Environmental conditions are essential for the proper functioning of V. fischeri
bioluminescence. A symbiotic culture produces approximately 1000-fold brighter
bioluminescence and more 3OC6-HSL than cultured cells at the same density.455
Therefore, HSLs are added to the cultures in vitro to induce quorum sensing and visible
bioluminescence. Figure 2.10 portrays V. fischeri cultures induced with high levels of
3OC6-HSL and C8-HSL.
V. fischeri cultures grown in the presence of 2 M 3OC6-HSL exhibited strong
bioluminescence and normal growth. When treated with concentrations of free -CD
ranging from 250 nM to 7 mM, the growth study showed that exposure to 2 mM  -CD
resulted in the most significant decrease in bioluminescence (Figure 2.11). A preliminary
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analysis of -CD functionalized nanoparticles with 2 M 3OC6-HSL demonstrated that
-CD was significantly more effective at dimming bioluminescence of V. fischeri when
functionalized as a monolayer to a nanoparticle than it was as a free compound (diagram
in Figure 2.12, results in Figure 2.13). In contrast, the -CD polymer coated nanoparticles
did not have a significantly different effect than free -CD on luminescence (Figure
2.14). Because 2 M 3OC6-HSL exceeds the expected HSL production of symbiotic
V.fischeri cultures, and does not induce the lux operon like C8-HSL, we altered the HSL
conditions to mimic the natural environment.
Growth experiments were repeated with V. fischeri cultured with 125 nM 3OC6HSL and 0.25 nM C8-HSL. Optical density and bioluminescence were monitored
throughout growth to determine the impact of free and functionalized -CD. All cultures
were grown in defined minimal medium,456 and therefore were not in a rich nutrient
environment. Additional growth studies indicated that the bacteria did not thrive on -CD
or the various Si-NPs. Also, when all carbon sources in the defined minimal medium
were replaced with -CD, no growth occurred. Cultures grown without the addition of
HSLs produced negligible levels of bioluminescence. Therefore, -CD, with or without
NPs, did not influence the growth or health of the cells.
V. fischeri cultures grown in the presence of 125 nM 3OC6-HSL and 0.25 nM C8HSL produced measureable bioluminescence; although, bioluminescence in general was
lower compared to the cultures treated with 2 M 3OC6-HSL (as indicated by the
different scales in Figure 2.13 and Figure 2.15). Our study found that at environmentally
relevant levels of HSLs, bioluminescence was significantly reduced in vitro by -CD. By
functionalizing -CD to 50 nm NPs, 133 nM -CD was able to produce the same result as
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a 2x higher concentration of free 250 nM -CD (Figure 2.15). We found that 15 nm SiNPs with or without -CD decreased bioluminescence to the same extent, and thus may
not have a significant role in dimming luminescence.
The long half-life (relative to a 12-hour growth experiment) of luciferase likely
contributed to the uncertainty in discerning subtle changes in quorum sensing over time.
To further examine the role of functionalized and free -CD in V. fischeri quorum
sensing, we then examined changes in transcription of the lux operon during exposure to
-CD and -CD functionalized Si-NPs.

2.5 TRANSCRIPTION OF THE lux OPERON DURING NANOPARTICLE
EXPOSURE
Bioluminescence in V. fischeri is generated by the lux operon and is activated by
3OC6-HSL and C8-HSL. Transcription of the lux operon results in the production of
luciferase, the enzyme responsible for bioluminescence. In this study, the fold change in
luxA and luxR transcription was quantified to determine the activity of the lux operon
during exposure to -CD. LuxA forms the alpha subunit of luciferase and was used to
monitor bacterial luminescence. LuxR is a receptor for both 3OC6-HSL and C8-HSL,
and initiates the lux operon, and was used to monitor signal production. Table 2.3
summarizes the fold-changes calculated from the Ct values generated by qPCR with the
Livak method (ΔΔCt) of both HSL-treated cultures.
The quantity of transcripts produced by untreated cultures (controls) and cultures
treated with 250 nM -CD were not markedly different, indicating that low
concentrations of free -CD are ineffective in down-regulating luxA and luxR at
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environmental levels of HSLs (data not shown). The addition of much higher (i.e. 2 mM)
-CD significantly reduced the expression of luxA and luxR transcripts, as indicated by
the calculated fold changes. In an attempt to more-efficiently deliver -CD to the
bacterial cell, low concentrations of -CD were delivered via Si-NPs. As Table 2.3
indicates, both the functionalized and non-functionalized 15 nm Si-NPs reduced the
expression of luxA and luxR transcripts to a similar extent. The data agree with the
growth study, indicating that the influence of 15 nm Si-NPs and 155 nM -CD
functionalized 15 nm Si-NPs is indistinguishable. Conversely, treatment with the larger
nanoparticles (i.e. functionalized and non-functionalized 50 nm Si-NPs) resulted in
significantly different fold changes. The 133 nM -CD, when bound to functionalized 50
nm Si-NPs, resulted in the greatest down-regulation of luxA and luxR transcripts out of all
treatments, demonstrating the strong utility of this size of functionalized silica
nanoparticles. The discontinuity of the bioluminescence measurements between the
growth and transcription studies was likely influenced by the relatively long half-life of
bioluminescence, which contributed to an inability to discern differences using
bioluminescence during growth.
The growth and transcription studies indicate that the 15 nm and 50 nm Si-NPs
resulted in different levels of bioluminescence, although both Si-NPs were synthesized
using the same method. Based on the nanoparticle synthesis methods and TGA analyses,
we determined that the 15 nm Si-NPs carry 0.06 mol -CD / mg Si-NP complex, while
the 50 nm Si-NPs carry 0.15 mol -CD /mg Si-NP complex, indicating that the surface
densities of the two Si-NPs are different. Additionally, the surface area of the 50 nm SiNPs is more than ten times the surface area of the 15 nm Si-NPs, which may have
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provided for more space between individual -CD molecules and allowed for more
efficient binding with the HSLs. Given that a 50 nm Si-NP can carry 1.7 times more CD than a 15 nm Si-NP, a higher dose of 15 nm Si-NPs was used to treat the samples to
achieve comparable levels of -CD. Three major possibilities exist to explain this. First,
the higher concentration of Si-NPs aggregated in solution, making more of the functional
groups unavailable on this size Si-NP. Alternatively, the -CD may have been too dilute
among the 15 nm Si-NPs and therefore did not act differently than dissolved -CD.
Lastly, it is possible that the 15 nm Si-NPs behave differently than 50 nm Si-NPs in an
aqueous solution.349, 457 It has been shown that the surface modifications of silica affect
the dispersion of Si-NPs, and that smaller-sized Si-NPs have unique physicochemical
properties and optical absorption characteristics.458 Therefore, smaller nanoparticles with
a low surface density may behave differently than larger nanoparticles with a higher
surface density. In summary, it is likely that the -CD dose carried by the 15 nm Si-NPs
behaved differently than the 50 nm Si-NPs, and therefore was unable to impact quorum
sensing more significantly than free -CD. The larger 50 nm Si-NPs, in contrast, were
able to carry a higher dose of -CD on fewer nanoparticles, and directly influenced
quorum sensing in V. fischeri.

2.6 CONCLUSION
In this study, we have demonstrated that functionalized silica nanoparticles can be
used to enhance the role of quenching agents in vitro. Specifically, we demonstrated that
-CD is able to bind HSLs and down-regulate bacterial quorum sensing genes. We have
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found that the quenching ability of -CD was much greater on functionalized 50 nm SiNPs, and provides a strong model for future designs.
The growth experiment was conducted with several forms of cyclodextrin to
determine an efficient binding agent for HSLs. We found that -cylodextrin and 2hydroxypropyl--cyclodextrin did not silence bacterial communication any more or less
efficiently than -cyclodextrin. However, we found that both 125 nM and 250 nM
methyl--cyclodextrin dimmed luminescence in vitro by 31.8% and 48.9%, respectively,
while 250 nM -cyclodextrin dimmed luminescence by 16.7% (calculated from data in
Figure 2.15). When functionalized to a nanoparticle, lower levels (133 nM) of -CD
dimmed luminescence by 33.3%. We are currently designing nanoparticles to carry low
levels of methyl--cyclodextrin in an effort to enhance the potency of the Si-NP complex.
In addition to more specific binding agents, we are also pursuing bacterial receptor
proteins that will bind signal molecules with high species specificity.
The importance of nanoparticle therapies is imperative to the treatment of biofilm
infections. One of the most significant challenges in the treatment of chronic infections is
delivering effective drugs to bacterial biofilms. Biofilms are surface-associated bacterial
communities living in a highly organized structure at a liquid interface,459-460 and have
been estimated to be responsible for 80% of hospital-acquired infections.460 The
protective nature of bacterial biofilms makes them able to physically limit antibiotic
penetration,419, 421, 423, 461 quickly regulate multidrug efflux pumps431, 460 and stress
response genes,462-463 induce a biofilm-specific phenotype,423-424, 426 and easily trade and
enhance antibiotic resistance genes among their bacterial members.435, 464 Here, with the
advent of nanotechnology, we have demonstrated a unique ability (and tool) to
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specifically target bacterial communication, which may be used to penetrate infectious
biofilms and eliminate infections.

2.7 METHODS
-CD ANALYSIS
Instrumentation
NMR diffusion measurements were performed on a Varian Mercury/VX 400
spectrometer operating at 400.273 MHz (1H). Pulsed-field gradient spin echoes with
varying gradient intensity were collected with the Doneshot pulse sequence that was
included with VNMRJ 2.2D software.465 The standard Varian Performa I pulsed field
gradient amplifier and 5 mm broadband probe were capable of producing a maximum of
20 gauss/cm field gradients. Spectra were taken at ambient temperature with bipolar
gradient pulses of 4 ms and a diffusion delay of 100 ms. All data processing was done
with the Varian DOSY software package.

GROWTH STUDIES
Bacteria and Growth Media
V. fischeri JB10 is a derivative of the ES114 strain that contains a chromosomal
gfp reporter within the lux operon, resulting in luxI-gfp-CDABEG.466 The strain was
prepared and obtained from Professor Eric Stabb (Univ. Georgia, Athens, GA). V.fischeri
JB10 was cultured from a glycerol stock and grown in marine broth (Difco 2216) to
exponential phase. The cells were then transferred to defined minimal medium456 for an
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optical density of approximately 0.1 (Abs600nm) for the growth and RNA extraction
experiments.

Bioluminescence response during exposure to nanoparticles
V. fischeri JB10 was grown in marine broth to exponential phase and then
transferred (0.5%) to a defined minimal medium.456 For growth experiments, 96-well
plates were incubated at 28°C in a Victor X Multilabel plate reader for 24 hours. Optical
density was measured at 600 nm and GFP fluorescence was measured with a 485/20 nm
excitation filter and a 528/20 nm emission filter. Bioluminescence was also measured. All
measurements were conducted every two hours for 24 hours following 10 seconds of
vigorous shaking. The total volume of each well was 200 L, which included either 250
nM -cyclodextrin, 2 mM -cyclodextrin, 15 nm SiO2 nanoparticles (2.75 x 10-3 mg/mL
NPs), 15 nm SiO2 nanoparticles functionalized with 155 nM -cyclodextrin (2.75 x 10-3
mg/mL NPs), 50 nm SiO2 nanoparticles (8.9 x 10-4 mg/mL NPs), or 50 nm SiO2
nanoparticles functionalized with 133 nM -cyclodextrin (8.9 x 10-4 mg/mL NPs).
Cultures also included 125 nM 3OC6-HSL, 0.25 nM C8-HSL, or both 125 nM 3OC6HSL and 0.25 nM C8-HSL. All treatments were added at time zero. A growth experiment
was also performed with 600 nm SiO2 nanoparticles (data not shown, no cell growth
occurred).
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QUANTITATIVE PCR AND TRANSCRIPT ANALYSIS
lux transcription during exposure to nanoparticles
V. fischeri JB10 was grown in marine broth to exponential phase and then
transferred (1%) to a defined minimal medium.456 Cultures were grown at 28°C and 200
rpm in 250 mL shake flasks with a working volume of 50 mL for 8 hours. Treatments
were added at 8 hours and exposure/growth continued for 4 hours. At 12 hours of total
growth, 2 mL of cells were harvested by centrifugation at 2000 x g (5 min). Cells were
treated with 2 mg/mL lysozyme in TE buffer for 10 minutes and then homogenized with
a needle and syringe. RNA was extracted with PureLink RNA Mini Kit (Ambion) and
on-column DNA digestion was performed with PureLink PCR Micro Kit (Invitrogen).
qPCR was performed on a BioRad CFX96 Real Time System with a C1000 Thermal
Cycler. Data was analyzed by the Livak method (∆∆Ct) and fold changes were
determined by using 2-∆∆Ct.
Primers were designed for luxR and luxA with NCBI’s Primer-BLAST. Primers
for 16srRNA were found in the literature.467 All primers were ordered from Integrated
DNA Technologies (Coralville, Iowa) and are listed in Table 3.4. Genomic DNA from V.
fischeri JB10 was amplified with the primers and sequenced by Selah Genomics
(Columbia, SC) to check the accuracy of the primers.

NANOPARTICLE SYNTHESIS
Materials
All chemicals were obtained from Fisher or Acros and used as received unless
otherwise specified. Trimethylsilyldiazomethane (2.0 M in hexanes) was obtained from
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TCI. 4-Cyanopentanoic acid dithiobenzoate (CPDB) anchored silica nanoparticles were
prepared according to the literature.285, 314 3-aminopropyldimethyl-ethoxysilane was
obtained from Gelest, Inc. (Morrisville, PA). Methacrylic acid (99.5%, Acros) were
purified by passing through an activated neutral alumina column. AIBN was
recrystallized from methanol before use.

Instrumentation
1

H NMR was conducted using CD3OD as the solvent with a Varian Mercury/VX

400 spectrometer. Molecular weights and PDI were determined using gel permeation
chromatography (GPC) equipped with a 515 HPLC pump, a 2410 refractive index
detector, and three Styragel columns. The columns consisted of HR1, HR3 and HR4 in
the effective molecular weight ranges of 100-5000, 500-30000, and 5000-500000,
respectively. The GPC used THF as eluent at 30 °C and a flow rate of 1.0 mL/min, and
was calibrated with poly(methyl methacrylate) standards obtained from Polymer
Laboratories. Samples were filtered through microfilters with a pore size of 0.2 μm
before injection. Infrared spectra were determined with a BioRad Excalibur FTS3000
spectrometer. UV-vis spectra were measured with a Perkin-Elmer Lambda 4C UV-vis
spectrophotometer. Infrared spectra were recorded with a PerkinElmer Spectrum 100
spectrometer. Thermogravimetric analysis (TGA) was conducted using a SDT Q600
TGA system (TA Instruments) with a temperature ramping from 25 °C to 900 °C at a rate
of 10 °C/min under nitrogen.
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Preparation of monolayer dye-labeled -CD functionalized silica nanoparticles
A DMF solution of -CD (70.56 mg, 62.16 mol), N,N'-dicyclohexyl
carbodiimide (DCC, 10.3 mg, 49.73 mol) and 4-dimethylaminopyridine (DMAP,
0.5063 mg, 4.144 mol) were added to a 15 mL DMF solution of dye-labeled carboxylic
acid-functionalized silica nanoparticles (graft density: 0.24 groups/nm2, 0.7281g). The
reaction was stirred at room temperature overnight. The reaction solution was then
poured into 200 mL ethyl ether followed by centrifugation at 3000 rpm for 5 min. The
recovered particles were then redispersed in 20 mL of ethanol and subjected to dialysis
process to further remove impurities. The dye-labeled -CD coated silica nanoparticles
were finally dissolved in ethanol/water mixture solvents for further use.284

Preparation of polymer dye-labeled -CD grafted silica nanoparticles
A DMF solution of -CD (3.711 g, 3.27 mmol), N,N'-Dicyclohexylcarbodiimide
(DCC, 0.54 g, 2.616 mmol) and 4-Dimethylaminopyridine (DMAP, 26.6 mg, 0.218
mmol) were added to a 10 mL dry DMF solution of dye-labeled poly(methacrylic acid)
grafted silica nanoparticles (graft density: 0.30 chains/nm2, 252 mg). The reaction was
stirred at room temperature for overnight. Then the reaction solution was then poured into
200 mL ethyl ether followed by centrifugation at 3000 rpm for 5 min. The recovered
particles were then redispersed in 20 mL of ethanol and subjected to dialysis process to
further remove impurities. The dye-labeled poly(-CD) grafted silica nanoparticles were
finally dissolved in water for further use. This method is based on the work of Wang &
Benicewicz.285
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Table 2.1 Measured and corrected diffusion coefficients (D) for various mixtures of C8HSL and cyclodextrin. The dissociation constant (Kd) is calculated from equation 2. All
solutions were prepared in D2O.
Solution
composition

10 mM C8-HSL
5.3 mM C8-HSL
+ 23 mM -CD
8 mM C8-HSL +
8 mM  -CD
2 mM C8-HSL +
2 mM -CD
3 mM C8-HSL +
2 mM -CD
4 mM C8-HSL +
2 mM -CD

Measured
D x10-10 m2s-1
C8-HSL /CD
3.55

Corrected
D x10-10 m2s-1
C8-HSL /-CD

Kd
10-3 M

H2O

2.00

2.00

13.62

1.96

1.96

2.24

2.04

12.68

2.35

2.14

0.21

2.79

1.98

12.79

2.91

2.06

1.49

2.88

1.92

12.89

2.98

1.99

1.57

2.97

1.93

13.04

3.04

1.97

1.44

13.33

Table 2.2 Binding strength of -CD and C6-HSL or C8-HSL as determined by NMR.
C6-HSL

C8-HSL

Binding constant

0.11

0.69

Dissociation constant

9.05

1.44

Percent bound

17%

35%
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Table 2.3 Calculated fold change of transcription by V. fischeri after treatment exposures
to 125 nM 3OC6- and 0.25 nM C8-HSLs. Negative values indicate down-regulation.
luxR

luxA

no treatment (control)

-1.4

4.8

250 nM -CD

-1.7

1.7

2 mM -CD

-97.8

-39.1

15 nm bare-NPs

-250.4

-432.9

15 nm 155 nM -CD-NPs -245.7
50 nm bare-NPs

-629.77

-1723.4 -365.8

50 nm 133 nM -CD-NPs -2125.5 -2171.1

Table 2.4 Primer sequences used in qPCR.
Gene

Forward Primer

Reverse Primer

luxA

ATCCCCATCTTCGTGAACGG

ACAGAACATGGCCACGACAT

luxR

CGTGGGCGAGTGAAGGAAAA TGGCGCCAGTTAAAATTGCT

16s rRNA GTTTGATCATGGCTCAGATTG CTACCTTGTTACGACTTCACC
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Figure 2.1 N-acyl homoserine lactone, a chemical signal used by bacteria during quorum
sensing.

A

B

Figure 2.2 -cyclodextrin chemical (A) and toroidal (B) structure.

Figure 2.3 Schematic representation of monolayer -CD coated fluorescent silicon
dioxide nanoparticles. The black center sphere is the silicon dioxide core, and the white
outside rings represent the -CD.

80

Figure 2.4 1H NMR spectra of the as-synthesized -CD coated silica nanoparticles. (a)
before dialysis; (b) after dialysis.
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Figure 2.5 TGA of (a) dye-labeled monolayer carboxylic acid coated silica nanoparticles
(graft density: 0.18 groups/nm2); (b) dye-labeled monolayer -CD coated silica
nanoparticles.
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Figure 2.6 Schematic representation of a polymer grafted silica nanoparticle with -CD
side group. Gray center sphere represents the silica core and the white rings enlarged to
the right represent -CD.

83

Figure 2.7 TGA of (a) dye-labeled poly(methacrylic acid) grafted silica nanoparticles
(graft density: 0.18 groups/nm2); (b) dye-labeled poly(-CD) grafted silica nanoparticles.
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Figure 2.8 Photograph of dye-labeled poly(-CD) grafted silica nanoparticles in DMSO.

Figure 2.9 Acyl homoserine lactone molecules synthesized and recognized by V. fischeri.
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Figure 2.10 V. fischeri JB10 cultures in marine broth. Bioluminescence induced with
3OC6-HSL and C8-HSL.
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7 mM

5 mM

2 mM

500 nM

250 nM

no trt

Figure 2.11 Maximum relative bioluminescence per OD (600 nm) of V. fischeri during
exposure to -CD and 2 μM 3OC6-HSL. Error bars represent standard errors of the mean
(n=3). Asterisk indicates significance (P≤ 0.05).
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Figure 2.12 Schematic of nanoparticle-based silencing of bacterial quorum sensing.
(a) Diagram of V. fischeri lux operon during quorum sensing (QS). Triangles represent
3OC6-HSL. LuxR/3OC6-HSL complex initiates bilateral transcription of lux operon.
LuxI produces 3OC6-HSL. Inset: V. fischeri culture flask luminescing after treatment
with HSLs. (b) Diagram of V. fischeri during nanoparticle treatment. Binding of HSLs by
Si-NPs quenches QS and subsequent gene expression in lux.
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Figure 2.13 Changes in bioluminescence by V. fischeri during exposures to 2 μM 3OC6HSL, with either -CD or -CD functionalized Si-NPs. Error bars represent standard
error of the mean (n=3). Asterisks indicate significance (P≤ 0.05).
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Figure 2.14 Maximum relative bioluminescence per OD (600 nm) of V. fischeri during
exposure to 2 μM 3OC6-HSL and -CD or -CD functionalized 15 nm polymer
nanoparticles. Error bars represent standard error (n=3). Asterisks indicate significance
(P≤ 0.05).
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Figure 2.15 Mean relative bioluminescence per OD (600 nm) of V. fischeri during
exposure to 125 nM 3OC6-HSL and 0.25 nM C8-HSL treated with 250 nM -CD, bare
15 nm Si-NPs, 155 nM -CD functionalized 15 nm Si-NPs, bare 50 nm Si-NPs, or 133
nM -CD functionalized 50 nm Si-NPs. Error bars represent standard error of the mean
(n=3). Asterisks indicate significance (P≤ 0.05).
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CHAPTER 3
EXTRACELLULAR GLASS WITHIN EPS MATRIX IS A PROTECTIVE
STRATEGY FOR BIOFILMS AGAINST DESICCATION

Water-limitation and desiccation are common stressors encountered by microbial
communities at the fringes of aquatic and extreme environments. Microbes in these
environments are localized within the protective confines of biofilms surrounded in a
thick matrix of extracellular polymeric substances (EPS). Remarkably, desiccated
biofilms are able to rapidly resume cellular and extracellular activities upon rehydration.
How this process occurs, however, has remained elusive and constitutes a significant gap
in understanding resiliency in microbial cells.
Here we demonstrate a key step in this process: formation of an EPS glass within
the anhydrophilic microbial mats of Bahamian salt-ponds. EPS glass formation was
determined using differential scanning calorimetry (DSC). The functional integrity of
key extracellular molecules, called acylhomoserine lactones (AHLs), used in chemicalsignaling and diffusion-sensing, was preserved by vitrification in EPS glass during
desiccation, and allowed rapid-release and resumption of activity following rehydration.
AHLs were recoverable from dried mats stored for over seven years, and upon
rehydration AHLs were determined to be intact and functional using mass spectrometry
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(MS) and signaling bioassays, respectively. Glasses were formed in vitro using extracted
components of natural EPS. The disaccharide α-α-trehalose, an abundant component of
natural mat EPS, likely contributes in situ to glass formation and AHL stabilization.
Under laboratory conditions, AHLs were stabilized by trehalose-glasses. Other EPS
components, however, may additionally contribute to the natural glass as well. Solid-state
nuclear magnetic resonance (NMR) showed that trehalose stabilizes but does not directly
complex with AHLs during desiccation. The results show that preservation of AHLs
during desiccation provides microbial communities with the capability to resume
signaling and diffusion-sensing activities soon after rehydration. It is proposed that glass
formation may play roles in the broader resiliency of microbial life in many
environments.
Microorganisms frequently encounter water-limitation and survive desiccation in
many environments on the Earth’s surface.468 These environments exist on the fringes of
aquatic environments and in extreme environments, such as desert crusts, that have been
estimated to cover approximately 25% of the Earth’s terrestrial surface.468 Survival in
these environments is often localized within the protective confines of biofilms where
microbial cells are surrounded by a thick matrix of EPS.
Desiccation, defined here as the progressive loss of water, is a common stressor
that occurs with varying magnitude in coastal oceans, as rock varnish, in hypersaline
ponds, in the far reaches of desert crusts, terrestrial soils, intermittent freshwater ponds
and streams, and even the Antarctic Dry valleys,469 and in the fouling communities of
sidewalks, buildings, statues, and roof shingles.470 The extent of dehydration (to cells)
varies from environments where water is present much of the time, to environments

93

where water is intermittently present for only extremely brief periods (e.g., a few hours
per year). Therefore, the ability of microbial communities to adapt to water-limitation, or
even complete anhydrobiosis, is likely to be a very widespread process both in the
present day and throughout the history of life.
Microbial mats, located within the hypersaline ponds of San Salvador Island,
Bahamas, and other such environments, face a multitude of stresses such as diel changes
in temperatures, UV-irradiation, and rapid (minutes) to intermittent (seasonal) osmotic
challenges. They typically experience a wide range of salinities (10 to 340 ppt), intense
irradiance (> 2200 µE m-2 s-1), high temperatures (> 40oC), and chronic nutrient
depletion.471 The mats form well-defined horizontal layers that have previously been
described.471-474 Over an annual cycle, seasonally driven wet/dry conditions typically
result in a slow evaporation of water in ponds. Highest temperatures and salinities may
reach greater than 44oC and 340 ppt, respectively, during summer, and may be followed
by partial to complete desiccation. Sudden heavy rainfalls during July and August
commence the ‘wet season’ and contribute large pulses of freshwater to ponds. Thus, the
surface microbial mat communities may experience rapid shifts in ionic concentrations
(300 ppt shift) over a relatively short time interval (e.g. minutes to hours), yet they
remain metabolically active, and appear well-adapted to these environmental fluctuations.
One major adaptation that bacterial communities rely on to develop and survive is
quorum sensing. Quorum sensing is a communication mechanism that relies on chemical
signals to regulate essential microbial processes at high cell densities.475 The complex
communities within microbial mats utilize quorum sensing to coordinate gene
expression.475 A common group of chemical signals used by Gram-negative bacteria
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during quorum sensing are the acylhomoserine lactones (AHLs). AHLs contain a lactone
ring and a long acyl chain, and exist outside of the cells during transit. The length of the
acyl chain is essential to an AHL’s molecular stability, especially under extreme
conditions such as high or low pH.476-477 While, AHLs are subject to extreme
environmental conditions,478 the EPS may protect and facilitate the transfer of AHLs
among cells.479-480 The persistence of AHLs within an anhydrophilic microbial mat is
important to understanding the persistence of microbial communities under extreme
environmental conditions.
EPS are a common feature of microbial mats, and are especially apparent in
hypersaline systems.481 The EPS contribute a hydrated, but relatively permeable,
extracellular microenvironment for cells.482 This extracellular matrix is thought to
stabilize cells against rapid fluctuations in ions and nutrients,483 and has been shown to
aid in the desiccation-tolerance of soil bacteria.484-485 During the drying process, the EPS
typically condenses as salinity of the overlying water increases. When salinity reaches
180-200 g/L the EPS forms a tough, ‘leathery’ surface consistency. This corresponds to
the greatly reduced ability of ions in the overlying water to exchange with the inner mat
pore-water (Decho, personal communication). Finally, the EPS forms a hard, plastic-like
material that exhibit the properties of an organic ‘glass’ state. Glasses are often formed
by simple disaccharide sugars, and even polymeric molecules.486 They are extensively
used in dried foods to preserve taste, flavor, and shelf life. The glass state preserves
important molecules by preventing denaturation in the absence of water.487 Interestingly,
upon the addition of water, these communities of cells, can exhibit a relatively rapid (e.g.,
minutes to hours) recovery from anhydrobiosis.

95

At the level of the individual microbial cell(s), previous work has shown that
osmotic stress may occur through the net loss of water (from cells) and/or from increased
ionic changes.482 As salt stress increases, halophilic or halotolerant microorganisms have
evolved two basic intracellular pathways in order to compensate: a KCl-type and a
compatible-solute type of osmoadaptation.488-489 Bacteria utilize a range of major
osmolytes (e.g. glycerol, glycine-betaine, trehalose, glycine, B-glutamate and proline) to
compensate for increasing osmotic challenges.482, 490-491
An organic glass provides a matrix of very high-viscosity, which retards
damaging chemical reactions and deleterious physical events, such as fusion and crystal
formation,486 and may stop all chemical reactions that require molecular diffusion.492
Trehalose has a relatively high glass-transition temperature (Tg = 85-120°C) when
compared to other sugars,493 and therefore forms a type of amorphous solid with high
viscosity, at high temperatures.
Previous studies have shown that trehalose is commonly utilized intracellularly by
soil bacteria during periods of drought494 in order to maintain membrane stability495 and
preserve the structure of proteins.496 Trehalose is a non-reducing disaccharide that
consists of two glucose molecules linked by an , -1,1-linkage (α-D-glucopyranosyl αD-glucopyranosyl), and is often found in EPS.494 The very low hydration adjacent to the
glycosidic oxygen imparts conformational rigidity that allows trehalose to act as a sugar
template for stable interactions with hydrogen-bonded water molecules.497
In the present study, we have focused specifically on the role of trehalose as an
extracellular bioprotectant during desiccation, as it is a major component of
anhydrophilic microbial mats.471, 474 A fundamental examination was conducted to
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understand the role of glass formation in stabilizing certain quorum sensing signals,
called acylhomoserine lactones (AHLs), during desiccation under natural conditions. To
determine the ability of trehalose to protect constituents of microbial mats, we
additionally studied its role as a bioprotectant of the enzyme acylase. We hypothesized
that trehalose and other components of EPS may contribute to the enhanced persistence
of signals and other key extracellular molecules within resident microbial communities.

3.1 RESULTS
Bacteria and other microbial cells in a wide range of environments often undergo
reduced water-availability and desiccation. Herein is an examination of the microbial
mats of hypersaline ponds, which are characterized by a highly diverse and structured
community of bacteria and archaea within an abundant EPS matrix. These microbial
communities rapidly regain activity when rehydrated, even after prolonged desiccation.
EPS plays an important role in this process. As desiccation ensues, the EPS and
associated cells on the mat surface condense to form an impervious, leathery-like layer,
and eventually, a hard, plastic-like layer. The properties of dried mat EPS were examined
here to understand their role in microbial survival during desiccation.

Analysis of EPS in Salt Pond microbial mat
As seen in Figure 1, the desiccation of Salt Pond over time resulted in the
precipitation of salts on the surface of the mat. Previous studies have shown that the
salinity and temperature of Salt Pond typically increases throughout the dry season.498
Transition of the surface mats from wet to dry occurs in several steps that are closely
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related to seasonal patterns in precipitation and temperature. During the wet season
(approx. October-March), active microbial growth occurs in the Salt Pond surface mats
(Figure 3.1A). As the dry season commences, net loss of water, due to net evaporation
and higher surface temperatures, result in progressively higher salinities within Salt Pond
(Figure 3.1B). At high salinities (approximately 170 – 340 ppt), various salts begin to
come out of solution and co-precipitate on the mat surface. During this period, occasional
brief rains and wind slowly remove much of the evaporites from the surface, leaving a
coherent, leathery EPS surface (Figure 3.1C). Examinations with scanning electron
microscopy (SEM) showed that the surface consists of a continuous
crystalline/amorphous structure of primarily halite, with lesser amounts of gypsum,
anhydrite, and other salts (Figure 3.2). Transmission electron microscopy (TEM)
revealed thick EPS capsules surrounding desiccated cells (Figure 3.3).

Salt Pond EPS has a high abundance of glucose
EPS plays a critical role in providing structure and protection to the
microorganisms within a microbial mat (Figure 3.3). Figure 3.4 shows a vertical cross
section taken from a hydrated microbial mat in Salt Pond. The distinct colors of each
layer are due to the major constituent of each. The golden polymer layer (L1) is abundant
in diatoms, the green layer (L2) is abundant in cyanobacteria, and the purple/red layer
(L3) is abundant in sulfur and nonsulfur purple bacteria.499 Although dominated by
certain species, each layer contains a complex mixture of microorganisms. While each
layer contains EPS, the polymer layer (L1) contains the highest abundance of EPS.
Samples were collected throughout a standard vertical transect at stations in the Salt Pond
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mat,471 to measure EPS abundance, extending from the high-water region of the pond
(infrequently covered by water) to the low-water region (covered most of the year). At
each sample site, the uppermost layer of the microbial mat contained the highest levels of
EPS (Figure 3.5). The abundance of EPS on the surface of the mat and surrounding
individual cells may bestow some protection against the extreme environment to the
underlying mat and its resident microbes, respectively. To better understand the role of
EPS during desiccation, we investigated the composition of the EPS samples, and
performed laboratory tests to analyze the carbohydrate components.
EPS samples, collected from the Salt Pond microbial mat, were analyzed via gas
chromatography/mass spectrometry (GC/MS). The GC/MS analysis revealed the
presence of sugar monomers, including the neutral sugars glucose, galactose, mannose,
xylose, the 6-deoxyhexoses fucose, rhamnose, and arabinose, the uronic acids
glucoronate and galacturonate, and N-acetyl-D-glucosamine (Table 3.1). The relative
enrichment of deoxy-sugars has been shown to increase the hydrophobic nature of some
EPS.500 Methylation, detected in only trace amounts, can influence the conformational
and physical characteristics of the EPS and their hydrophobicity. In both the hydrated and
desiccated samples, glucose was found to have the highest mole percentage of the total
mass. Glucose is often a dominant sugar in EPS.500-501 The high concentration of glucose
may indicate the presence of trehalose, but could not be distinguished in these analyses.
Trehalose is an ,-1,1-linked disaccharide of glucose, and has been shown to play a role
in osmoprotection. Osmoprotection is crucial to the survival of microorganisms in
extreme environments, such as the high salinity and high temperature environment found
in Salt Pond.
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Trehalose forms glass in EPS during desiccation
To study the ability of EPS to form a glass in the microbial mat, and to
demonstrate the role of EPS as an osmoprotectant, we isolated EPS from Salt Pond. The
sample was dried and analyzed via differential scanning calorimetry (DSC) and
thermogravimetric analysis (TGA). Trehalose dihydrate and anhydrous trehalose were
also dried and used as standards. DSC revealed that both trehalose dihydrate (Figure 3.6)
and trehalose anhydrous (Figure 3.7) resulted in phase transitions at 85°C, indicating the
presence of a glass.493 DSC also detected phase transitions at the melting points of
trehalose dihydrate and trehalose anhydrous, as was expected. The DSC analysis of the
Salt Pond extract revealed that the EPS sample contained several compounds, many of
which experienced phase transitions (Figure 3.8). Furthermore, TGA confirmed the
presence of several compounds in the EPS sample, including trehalose dihydrate (Figure
3.9), as seen in Figure 3.10. The DSC and TGA results verified that the EPS sample
contained trehalose, and that both trehalose dihydrate and anhydrous trehalose are able to
form a glass.

C6-AHL subject to degradation in salt water
The common bacterial quorum sensing signal molecule, N-hexanoyl-Lhomoserine lactone (C6-AHL), is frequently found in microbial mats. To investigate the
heat tolerance of C6-AHL, it was tested in solution at varying temperatures. The results
indicated that C6-AHL retained activity at 25, 35, and 45° C. Activity was not detected
after exposure to 55 or 65° C. Signal activity was determined by the presence of
pigmentation in the biosensor C. violaceum CV026. The microbial mat presents a
complex environment to signal molecules, and therefore the signal molecules may utilize
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several other components to maintain activity at high temperatures. To explore the role of
salt in the preservation of C6-AHL, salt water samples from Salt Pond were added to the
experimental solution.
Long term (3 days) exposure to 55° C in high salt solutions was tested to
determine if the natural salt water environment provided protective elements to the signal
molecule. Water samples collected from Salt Pond in San Salvador, Bahamas were used.
The C6-AHL was dissolved in small volumes of salt water and dried over the course of
three days. The initial salt concentrations were 280 ppt, 140 ppt, 70 ppt, and 35 ppt.
Sodium chloride (NaCl) was used as the control. C6-AHL dried in 28 ppt (normal salt
concentration of ocean) Salt Pond water retained activity. However, C6-AHL did not
retain any activity after desiccation at 55° C in solutions of 280 ppt, 140 ppt, 70 ppt, or 35
ppt Salt Pond water. A qualitative analysis of the water sample from Salt Pond was
performed via ICP-MS. The analysis showed that the sample contained numerous trace
metals, including calcium, manganese, and magnesium. Interestingly, C6-AHL dissolved
in 280 ppt Salt Pond water and stored at room temperature also lost activity after three
days.
This experiment was repeated with gentle heating over a longer time period to
better mimic the microbial mat environment. After heating at 35°C to dryness (five days),
neither the Salt Pond water samples nor the pure NaCl samples retained C6-AHL activity.
To ensure that the biosensor was providing accurate results, we used the parent strain of
C. violaceum to test for quorum sensing inhibitors. Neither the high salt solutions of Salt
Pond water or NaCl inhibited quorum sensing in C. violaceum. These results indicate that
C6-AHL activity is dependent on both the temperature and duration of heating. Given the
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complexity of a microbial mat, we next explored the role of trehalose as an
osmoprotectant during desiccation.

Trehalose provides protection to C6-AHL during desiccation
To investigate the heat tolerance of C6-AHL in the presence of trehalose, samples
were subjected to high heat. Solutions of C6-AHL and trehalose were heated at either
50°C or 60°C for five days. The 60°C heat treatment was followed by exposure to 100°C
for 15 minutes to ensure the formation of a trehalose glass. Both experiments were
conducted at pH 7.5 and pH 11, two conditions commonly found in microbial mats. A
third component, the enzyme acylase, was also added to the solution to determine if
trehalose could provide protection to an enzyme during desiccation.
For the experiment conducted at 50°C, the results indicated that activity of C6AHL was maintained after trehalose glass formation with and without acylase at both pH
7.5 and pH 11. Signal activity was determined by the biosensor C. violaceum CV026, as
seen in Table 3.2. These results suggested that C6-AHL is tolerant of long term exposure
to 50°C in the dehydrated state in the presence of trehalose. Interestingly, C6-AHL was
also tolerant of the pH 11 environment in the presence of trehalose although, typically,
high pH environments destabilize homoserine lactones. Under these conditions, acylase
activity was not preserved.
For the experiment conducted at 60°C and 100°C, the results indicated that C6AHL tolerated heat treatment in the presence of trehalose at pH 7.5. However, C6-AHL
activity was not preserved in the presence of trehalose at pH 11. And, once again under
both conditions, acylase activity was not preserved. It is likely that the acylase was
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activated at pH 11, and destroyed the C6-AHL before being degraded by heat. The data is
presented in Table 3.2.
To verify the formation of a trehalose glass and to determine if any structural
changes occurred in the sample, solid state NMR spectroscopy was performed. As
before, the samples were subjected to heat treatment at 60°C for five days followed by
100°C for 15 minutes at pH 7.5. The higher temperature conditions were used in this
experiment to ensure that all residual water was removed from the samples before
analysis. The NMR spectra of both heat-treated and untreated trehalose and trehalose
with C6-AHL can be seen in Figure 3.11. The spectra indicate that the structure of C6AHL was not altered by heat treatment with (Figure 3.11B) or without (Figure 3.11A)
trehalose present. These results correspond with the biosensor data presented in Table
3.2. As expected, the structure of trehalose was altered by heat treatment, as can be seen
by comparing Figure 3.11C and Figure 3.11D. The heat treatment of trehalose resulted in
broad, unresolved resonances due to the highly disordered molecules and amorphous
state of the glass (Figure 3.11C). The untreated trehalose samples appear highly
crystalline in structure (Figure 3.11D). In the presence of C6-AHL, the trehalose spectra
indicated a glass structure (Figure 3.11B). These results suggest that the glassy state of
the trehalose is not influenced by the presence of C6-AHL. Also, the heat treatment does
not change the resonances or the structure of C6-AHL in the presence or absence of
trehalose. The spectra of heat-treated C6-AHL alone (data not shown) was identical to the
untreated C6-AHL spectra (Figure 3.11A) and the spectra of the heat-treated trehalose
with C6-AHL (Figure 3.11B). Ultimately, this experiment demonstrated that trehalose
forms a glass at high temperatures, the structure of which is not influenced by C6-AHL.
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Together, the C6-AHL assay and the solid state 13C NMR spectroscopy illustrate
that C6-AHL alone was tolerant of the 50°C treatment, but not the 60°C / 100°C
treatment. The fact that C6-AHL activity was preserved at the higher treatment in the
presence of trehalose suggests that trehalose plays a role as an osmoprotectant. Given that
our model relies on a simple system, and lacks the complexity of an environmental
microbial mat, we further studied the role of divalent cations during glass formation.

Divalent cations stabilize enzyme during desiccation
To further analyze the activity of acylase during glass formation, and to determine
if its activity is being preserved in the model system, an enzymatic assay was performed
after heat treatment. The initial glass samples containing acylase, described in Table 3.2,
did not have any enzymatic activity after glass formation. It is known that some enzymes
within microbial mats are stabilized by interactions with carbohydrates. However, given
that our system simply mimics a microbial mat, and is lacking several of the key
components therein, we added a variety of divalent cations in an attempt to further
stabilize acylase.
The study found that the presence of manganese at pH 11 during heat treatment
resulted in high enzymatic activity. At pH 7.5, calcium was most effective at preserving
enzymatic activity. As seen in Table 3.3, we looked at glucose, trehalose, and dextran,
and the dissolved cations manganese, magnesium, and calcium. In each case, we found
that dissolved cation alone with acylase was not enough to preserve activity (data not
shown). However, in some cases the addition of glucose, trehalose, or dextran during heat
treatment aided in preserving the activity of acylase. The results of the glass formation
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experiment and the acylase analysis indicated that several interactions within a microbial
mat may be responsible for preserving the integrity of these compounds.

C6-AHL loses activity in high salt solutions
In an effort to mimic the natural microbial environment, the heat tolerance of C6AHL was tested in a high salt solution. C6-AHL was dissolved and then dried in salt
water collected from Salt Pond (280 ppt)
Trehalose is a common constituent of microbial mats, and is believed to provide
some protection to small molecules during desiccation. To determine if the presence of
trehalose aided in the retention of C6-AHL activity during exposure to 55° C, it was
added to the experimental solution of salt water and C6-AHL. After drying for three days
at 55° C in the presence of Salt Pond water, NaCl, or deionized water, C6-AHL was
inactive.
Once again, the experiment was repeated with gentle heating over a longer time
period to better mimic the microbial mat environment. The samples were heated at 35° C
to dryness over the course of five days. The samples were then heated briefly at 55° C to
remove residual water and force the trehalose to transition to a glass. C6-AHL did not
retain activity under these conditions (in water, in salt water, or in NaCl) with or without
trehalose present. Surprisingly, the trehalose did not act as an osmoprotectant in this case.
These results indicate that the complex microbial mat ecosystem requires other
compounds in addition to trehalose to preserve quorum sensing signal molecules.
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3.2 DISCUSSION
Microorganisms have evolved to survive in extreme environments through a
number of adaptations. Microbial mats consist of a structured, laminated community that
allows microorganisms to survive and thrive in extreme environments. The hypersaline
mat system in Salt Pond on San Salvador Island, Bahamas, experiences dramatic seasonal
shifts in precipitation, ionic concentrations, and water availability. These shifts create an
extreme environment for the resident microorganisms. Annual rainfall on San Salvador
Island is approximately 100 cm, and evaporation exceeds precipitation most years.
Rainfall is dependent on tropical storms, hurricanes, and related cyclical weather patterns.
Consequently, the majority of precipitation occurs during the months of September and
October. After the onset of the dry season, large areas of the mats become and remain
desiccated for much of the year. The water level, salinity, and extent of desiccation for
Salt Pond mats are therefore, closely linked to rainfall. Salinity is largely dominated by
univalent ions (e.g. Na+ and Cl-)502 and a wide variety of trace metals. When compared to
mats in more temperate climates, the San Salvador mats exhibit lower CO2 and N2
fixation.471, 474 The extreme temperature and salinity during the dry season creates a
hypersaline environment in the microbial mat. Average temperatures reached above
40°C, with the salinity steadily increasing to 300 ppt throughout the dry season.498 There
are several key components within microbial mats that allow microorganisms to respond
to these extreme conditions and survive.
Foremost, we theorize that the abundance of EPS in the microbial mat acts as a
physical shield for the lower layers. The image of the dried Salt Pond mat (Figure 3.1)
shows the thick upper crust of salt that protects the surface of the microbial mat. SEM
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imaging confirmed that the upper layer of the microbial mat contained crystalline and
amorphous polysaccharides, both of which provide a physical barrier to UV radiation and
oxidative damage. Furthermore, we found that EPS was most abundant in the top most
layer of the mat (Figure 3.5). The EPS of the Salt Pond microbial mat contained a wide
variety of monosaccharides, most notably glucose. We suggest that the high
concentration of glucose may be inclusive of a high trehalose concentration. Of the
polysaccharides, trehalose forms the most stable glass, and is often used by the food
industry as a preservative and stabilizer.
We next investigated the ability of divalent cations to stabilize enzymes during
desiccation. We found that in the presence of glucose, trehalose, and dextran, calcium
and manganese enhanced the stability of acylase during heat treatment.

Desiccation

increases potential for UV damage and oxidative damage; therefore we investigated the
potential protective elements within the microbial mat. Trehalose is a ,-1,1-linked
glucose disaccharide that often provides osmoprotection and stability to small molecules.
Trehalose is a major component of EPS, and is able to form a glass at high temperatures.
We have observed biological activity in previously desiccated microbial mats after
periods of rainfall. We theorize that trehalose plays a role in preserving microorganisms
and small molecules during desiccation and throughout the dry season. Here we have
provided evidence that trehalose protects the quorum sensing signal molecule C6-AHL at
high temperatures. Trehalose is able to form a glass at temperatures above 55°C, the
structure of which does not modify the structure of C6-AHL. Normally, C6-AHL would
be degraded by high temperatures. Interestingly, we could not demonstrate the protective
properties of trehalose in the presence of high salts. We theorize that several components

107

may be responsible for the preservation and osmoprotection of C6-AHL during
desiccation.
A second compound, acylase, was also investigated in the presence of trehalose.
We found that acylase was not able to withstand high temperatures, and was not aided by
the presence of trehalose. However, acylase activity was improved when the enzyme was
dried in the presence of divalent cations, specifically calcium and manganese. Salt Pond
contains both of these cations in abundance, and is frequently flooded with sea water,
where these cations are also present. The polysaccharides of EPS are known to retain and
stabilize enzymes. Several trace metals are found in Salt Pond water, and may contribute
to the formation of a protective layer of EPS.

3.3 CONCLUSION
This study showed that the formation of an organic glass occurred during
desiccation of EPS at the Salt Pond microbial mat. Formation of the glass preserved the
integrity and viability of cells, and the activities of important extracellular signal
molecules for several years. Chemical communication is a crucial process guiding
interactions among bacteria and archaea in hydrated conditions. AHLs were preserved in
the extracellular microbial glass during dehydration of natural mats and were able to
commence signaling upon rehydration. Under laboratory conditions, AHLs were
protected in the presence of trehalose, a glass-forming disaccharide, which is abundant in
the EPS of natural mats. Other EPS components may have also contributed the AHL
preservation. Using solid state NMR, trehalose was shown to undergo a structural change
and prevent denaturation of AHLs during desiccation. The trehalose/AHL complex
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‘dissolved’ upon rehydration and allowed AHLs to resume signaling activity. It is
proposed that glass formation has implications for the broader resiliency of microbial life
in many environments.
Overall, this study suggests that trehalose glass may play an important role in
preserving the integrity of quorum sensing signals and bacterial enzymes in a high
salinity anhydrophobic microbial mat. Further investigations of environmental samples
and higher complexity laboratory models are needed to fully understand the role of
trehalose as an osmoprotectant.

3.4 MATERIALS AND METHODS
Sample Collection: Natural Mats
All samples were collected from Salt Pond, located near the northeastern end of San
Salvador Island, Bahamas (24o05' N, 74o30' W). Intact mat samples (6 x 6 cm) were
collected to a depth of approximately 2 cm and then returned to the Grice Research
Center laboratory on San Salvador Island for further processing. For EPS analyses, the
samples were sectioned into 1 mm thick slices under a dissecting microscope using sterile
razor blades. The samples were transferred to 50 mL tubes and extracted (within 1 hour
of collection) in the laboratory. The EPS sample was extracted with ethanol and dried at
35°C for several days.

Glass Formation
Solutions of 0.2 mg of glucose, trehalose, or dextran were prepared in sterile deionized
water and incubated in open-top glass tubes at 50°C for 5 days on a heating block. Some
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samples contained 0.1 mg N-hexanoyl-L-homoserine lactone (Cayman Chemical, Ann
Arbor, MI) and/or 200 units acylase I from porcine kidney (Sigma-Aldrich). The first
experiment was conducted at 50°C for five days to mimic the environment of a natural
microbial mat. The second experiment was conducted at 60°C for five days followed by
15 minutes at 100°C to ensure the formation of a glass.

Solid State NMR Spectroscopy
Solid state NMR spectroscopy was conducted on samples of treated (glass) and untreated
(control) trehalose and C6-AHL. Samples were incubated at 60°C for five days, followed
by 15 minutes at 100°C. The pH of the samples was 7.5. Solid state 13C CP-MAS spectra
were collected on a Bruker Avance III-HD 500 MHz spectrometer fitted with a 1.9 mm
MAS probe. The spectra were collected at ambient temperature with sample rotation rate
of 20 kHz. 1.5 msec contact time with linear ramping on the 1H channel and 62.5
kHz field on the 13C channel were used for cross polarization. 1H dipolar decoupling was
performed with SPINAL64 modulation and 145 kHz field strength. Free induction
decays were collected with a 27 msec acquisition time over a 300 ppm spectra width with
a relaxation delay of 1.5s.

Quorum Sensing Signal Detection
Chromobacterium violaceum CV026 (provided by Professor Robert McLean of Texas
Tech University) was used to detect N-hexanoyl-L-homoserine lactone (C6-AHL). Glass
samples were resuspended in 50 L sterile deionized water and allowed to rehydrate at
room temperature for 10 minutes. 10 L of this solution was applied to a sterile paper
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disk on Luria Bertram (30 g/L) agar plates inoculated with C. violaceum CV026. Plates
were incubated at 30°C overnight. The production of a violet pigment by the bacteria
indicated the presence of C6-AHL.

Temperature tolerance of C6-AHL
5 µM solutions of C6-AHL in water were subjected to 30 minutes of heat at 25, 35, 45,
55, and 65° C. Signal activity was determined by the biosensor C. violaceum CV026. The
C6-AHL was dissolved in small volumes of Salt Pond water and dried over the course of
three days at both 35 and 55° C. The initial salt concentrations were 280 ppt, 140 ppt, 70
ppt, and 35 ppt. Pure NaCl was used as the control in the same concentrations. The
experiment was repeated with 1 mM trehalose added to the solutions.

Acylase I Enzymatic Assay
Acylase I was detected by spectrophotometric analysis according to Mitz & Schlueter
(1958). Briefly, the decrease in absorbance at 238 nm was observed every minute for five
minutes for solutions containing the treated (in glass) or pure (control) acylase I and 100
mM potassium phosphate and 14 nM N-acetyl-L-methionine (Sigma-Aldrich). The
number of units/mL enzyme was determined by A238nm/min Test - A238nm/min
Blank)(60)(3)(dilution factor) / (0.019)(0.1).

Glass Experiment with Cations
Divalent cations were added to solutions of glucose, trehalose, or dextran at pH 7.5 or pH
11. Samples were comprised of 0.2 mg sugar, 200 units acylase I, and 0.1 mg dissolved
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cation from either MnCl2⦁4H2O, CaCl2, NaCl, or MgCl2⦁6H2O. Samples were heated in
open-top glass tubes at 50°C for five days. After incubation, samples were resuspended in
deionized water and acylase activity was determined spectrophotometrically with the
aforementioned assay.

DSC, TGA, and ICP-MS
DSC was performed with a Q2000 Differential Scanning Calorimeter (TA Instruments,
USA). Approximately 10 mg of sample was loaded into non-hermetic aluminum Tzero
pans. An empty aluminum pan was used as a reference for all experiments. The heating
rate was 10° C/min to 300° C under nitrogen flow. TGA characterization was performed
with a Q500 Thermogravimetric Analyzer (TA Instruments, USA). Approximately 10 mg
of sample was heated at a rate of 10 °C /min to 950 °C under nitrogen flow. Data were
recorded by the instrument software. A qualitative trace metal analysis of water from
Salt Pond was performed via inductively coupled plasma (ICP) – quadrupole mass
spectrometry on a Thermo Finnigan Element XR ICP-MS.
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Table 3.1 Composition of sugar monomers within EPS extracted from natural mats.
Carbohydrate monomer composition of EPS isolated from the upper layer of microbial
mat as determined by GC/MS. Values represent mole percentage of total mass. N=2
Monomer

Hydrated

Desiccated

Arabinose

4.2

2.1

Rhamnose

7.6

11.8

Fucose

10.6

4.9

Xylose

16.3

13.3

Glucuronate

7.6

5.5

Galacturonate

4.7

2.5

Mannose

9.3

13.7

Galactose

8.9

17.5

Glucose

24.4

28.7

N-acetyl glucosamine

6.2

--

Unknown

0.2

--

Mass % of Carbohydrate of EPS

28%

31.4%

113

Table 3.2 C6-AHL activity in trehalose as determined by pigmentation response of C.
violaceum CV026. ‘Yes’ indicates the presence of a violet pigment during bacterial
growth, which is produced in response to C6-AHL. ‘No’ indicates the absence of a
response. Samples were incubated at 50°C for five days or 60°C for five days followed
by 100°C for 15 minutes.
50°C

60°C/100°C

C6-AHL

Yes

Yes

C6-AHL + Acylase I

Yes

Yes

C6-AHL

Yes

No

C6-AHL + Acylase I

Yes

No

pH 7.5

pH 11

Table 3.3 Acylase activity in sugar after heat treatment at 50°C for five days at pH 7.5
and pH 11.
Glucose

Trehalose

Dextran

Mn

None

None

None

Mg

None

None

None

Ca

None

Low

Low

Mn

High

High

High

Mg

None

None

None

Ca

None

None

None

pH 7.5

pH 11
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A

B

C

Figure 3.1 Natural microbial mats collected from Salt Pond on San Salvador Island,
Bahamas showing wet- (A) and dry- (B, C) season sections of mat surface. Note
underlying layer abundant in cyanobacteria during wet season (A). During early dryseason, evaporites, including gypsum and halite, begin to appear as salinity increases (B),
and eventually encrust the dry surface mat (C).
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Figure 3.2 SEM of dried surface layer of microbial mat. Sample consists of a continuous
crystalline/amorphous structure of primarily halite, with lesser amounts of gypsum,
anhydrite, and other salts.

Figure 3.3 TEM of dry, natural microbial mats showing intact cells surrounded by a
dense capsular layer of EPS.
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L1
L2
L3

Figure 3.4 Vertical cross-section of microbial mat in Salt Pond showing distinct layering
of microbial groups. The uppermost surface Layer (L1) is the layer containing abundant
EPS, diatoms, archaea, as well as salt precipitates (during dehydration); Layer 2 (L2) is
the dense green ‘cyanobacteria-rich’ layer; Layer 3 (L3) is a layer dominated by purple
sulfur bacteria.

EPS Abundance Across Hydration Gradient

ug EPS per mg Cell Biomass

3.0
Surface Layer (L1)
Layer 2 (L2)
Layer 3 (L3)

2.5

2.0

1.5

1.0

0.5

0.0

S1

S2

S3

S4

S5

SITE

Figure 3.5 Abundances of EPS isolated from surface layers of hypersaline mat in Salt
Pond, San Salvador Island, Bahamas. Surface Layer (L1) is the layer containing the salt
precipitate and polymers; Layer 2 (L2) is the dense green ‘cyanobacteria’ layer; Layer 3
(L3) is the layer dominated by purple sulfur bacteria.
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Tg

Figure 3.6 DSC thermogram recorded upon heating of trehalose dihydrate at rate of
10°C/minute. The sample was dried for five days at 35°C prior to analysis. The small
shoulder at 85°C indicates a discontinuity in heat flow as the sample transitioned to the
glassy state and absorbed heat (Tg). The large peak corresponds with the melting point of
trehalose dihydrate (97°C).
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Tg

Figure 3.7 DSC thermogram recorded upon heating of trehalose anhydrous at rate of
10°C/minute. The sample was dried for five days at 35°C prior to analysis. The small
shoulder at 85°C indicates a discontinuity in heat flow as the sample transitioned to the
glassy state and absorbed heat (Tg). The larger peak corresponds with the melting point of
trehalose anhydrous (203°C).
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Tg

Figure 3.8 DSC thermogram recorded upon heating of Salt Pond EPS at rate of
10°C/minute. The sample was dried for five days at 35°C prior to analysis. The multiple
shoulders and peaks indicate the transition temperatures (Tg) of multiple compounds.
Specifically, the Tg of trehalose can be seen at 85°C.
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Figure 3.9 TGA thermogram of trehalose dihydrate recorded upon heating at rate of
10°C/minute. The sample was dried for five days at 35°C prior to analysis. The green line
represents weight loss occurred. The blue line represents the first derivative of the weight
loss curve. The inflection point, the greatest rate of change on the weight loss curve
(green), is indicated by the peak of the first derivative curve (blue).
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Figure 3.10 TGA thermogram of Salt Pond EPS recorded upon heating at rate of
10°C/minute. The sample was dried for five days at 35°C prior to analysis. The small
peak at 300°C corresponds with the peak expected for pure trehalose dihydrate. The blue
line represents the first derivative of the weight loss curve. The inflection point, the
greatest rate of change on the weight loss curve (green), is indicated by the peaks of the
first derivative curve (blue).
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A

B

C

D

Figure 3.11 Solid state 13C NMR spectra of (a) untreated C6-AHL, (b) heat-treated C6AHL with trehalose, (c) heat-treated trehalose, and (d) untreated trehalose.
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